<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bipolar disorder in adults: Clinical features</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bipolar disorder in adults: Clinical features</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bipolar disorder in adults: Clinical features</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Trisha Suppes, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Paul Keck, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Solomon, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 28, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H11685817"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Bipolar disorder frequently disrupts mood, energy, activity, sleep, cognition, and behavior, as well as occupational and interpersonal functioning [<a href="#rid1">1</a>]. Out of 328 diseases that were studied worldwide in 2016, bipolar disorder was the 23<sup>rd</sup> leading cause of years lived with disability [<a href="#rid2">2</a>]. Pharmacotherapy within the context of a positive therapeutic alliance is central to managing morbidity and the risk of suicide. However, treatment following onset of the disorder is typically delayed for years [<a href="#rid3">3</a>].</p><p>This topic reviews the clinical features of bipolar disorder in adults. The assessment, diagnosis, and treatment of bipolar disorder in adults are discussed separately, as are the clinical features and diagnosis of bipolar disorder in children and adolescents, geriatric patients, and patients with rapid cycling (ie, four or more mood episodes in a 12-month period):</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15267.html" rel="external">"Bipolar major depression in adults: Choosing treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/679.html" rel="external">"Bipolar mania and hypomania in adults: Choosing pharmacotherapy"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/680.html" rel="external">"Bipolar disorder in adults: Choosing maintenance treatment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15924.html" rel="external">"Pediatric bipolar disorder: Clinical manifestations and course of illness"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/83083.html" rel="external">"Pediatric bipolar disorder: Assessment and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14650.html" rel="external">"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15249.html" rel="external">"Rapid cycling bipolar disorder: Epidemiology, pathogenesis, clinical features, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H976713"><span class="h1">DEFINITION OF BIPOLAR DISORDER</span><span class="headingEndMark"> — </span>According to the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), and the World Health Organization's International Classification of Diseases 11<sup>th</sup> Revision (ICD-11), bipolar disorder is characterized by mood episodes that consist of mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), and major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>) [<a href="#rid1">1,4</a>]. Mania and hypomania compose one pole of the disorder, and major depression the other pole.</p><p>The subtypes of bipolar disorder include bipolar I disorder and bipolar II disorder. Patients with bipolar I disorder experience manic episodes and nearly always experience major depressive and hypomanic episodes. Bipolar II disorder is marked by a history of at least one hypomanic episode, at least one major depressive episode, and the absence of manic episodes. The table  (<a class="graphic graphic_table graphicRef89746" href="/z/d/graphic/89746.html" rel="external">table 4</a>) compares diagnostic features for the two subtypes. Additional information about diagnosing bipolar disorder is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis"</a>.)</p><p>Although some studies have separately examined and compared the clinical features of bipolar I disorder and bipolar II disorder [<a href="#rid5">5</a>], most studies have combined the two subtypes.</p><p class="headingAnchor" id="H11685824"><span class="h1">CLINICAL PRESENTATION</span></p><p class="headingAnchor" id="H589127877"><span class="h2">Overview</span><span class="headingEndMark"> — </span>Bipolar disorder can present with mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>), mixed features (mood episodes that are accompanied by concurrent symptoms of the opposite polarity), or psychotic features (eg, delusions or hallucinations) [<a href="#rid1">1,6</a>]. The severity of these syndromes varies widely across patients, as well as within an individual patient during the lifetime course of illness, and subsyndromal symptoms are common [<a href="#rid7">7-9</a>]. In addition, some symptomatic patients remit and become euthymic, while other patients transition immediately from one type of syndrome to another (eg, from major depression to mania) without an intervening period of euthymia [<a href="#rid10">10</a>].</p><p>The mood episode at onset of bipolar disorder is usually major depression [<a href="#rid11">11</a>]. In a study of 2308 patients, the first lifetime episode was [<a href="#rid12">12</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Major depression in 54 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Mania in 22 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Mixed (concurrent symptoms of major depression and mania) in 24 percent</p><p></p><p class="headingAnchor" id="H975366"><span class="h2">Prodrome</span><span class="headingEndMark"> — </span>Many studies indicate that mood and nonmood prodromal signs and symptoms, such as irritability, anxiety, elevated mood, depressed mood, mood lability (“mood swings”), agitation, aggressiveness, disruptive behavior disorders (eg, conduct disorder), sleep disturbance, hyperactivity, and psychotic experiences (delusions or hallucinations) may precede onset of diagnosable bipolar disorder [<a href="#rid13">13-18</a>]. However, prodromal symptoms are nonspecific and their predictive value is uncertain. The same symptoms can occur during the prodrome of other psychiatric disorders, and the proportion of patients who experience a prodrome varies widely across studies.</p><p class="headingAnchor" id="H11685831"><span class="h2">Mania</span><span class="headingEndMark"> — </span>Manic episodes  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>) involve clinically significant changes in mood, energy, activity, behavior, sleep, and cognition  (<a class="graphic graphic_table graphicRef86880" href="/z/d/graphic/86880.html" rel="external">table 5</a>) [<a href="#rid1">1,6</a>]. For any one patient, it is not known whether the symptom profile of mania is consistent across different episodes. However, episodes are often similar within a given patient for at least some portion of the lifetime course of illness. As an example, a patient prone to euphoric mania is likely to experience repeated episodes of euphoric mania unless substance abuse, head injury, or duration of illness leads to a change in presentation, such as mania with mixed features (ie, mania with co-occurring depressive symptoms).</p><p>Abnormally elevated, expansive, or irritable mood is a core symptom required to diagnose mania [<a href="#rid1">1</a>]. Classic mania is marked by an unusually good, euphoric, or high mood, which may be accompanied by disinhibition (eg, wearing garish clothes or disrobing in public), disregard for social boundaries, expansiveness, and a relentless pursuit of stimulation and social activities (eg, sexual behavior, spending more money than usual, renewing old friendships, or lengthy telephone calls with strangers) [<a href="#rid19">19</a>]. The elevated mood may have an infectious quality that initially engages others; however, patients may appear to be insensitive to the needs of others. As manic episodes worsen, more driven and extreme behavior can emerge.</p><p>Another core symptom required to diagnose mania is persistently increased energy and activity [<a href="#rid1">1</a>]. During mania, increased planning and activity is typically marked by impulsivity, poor judgement, and disregard for risks [<a href="#rid1">1,20</a>]. Examples include taking on new and foolish business ventures, unaffordable spending sprees, sexual infidelity or sexual encounters with strangers, and driving recklessly. In addition, patients are often unable to complete the many tasks or projects that are started. Two independent nationally representative surveys in the United States and a third survey in Australia, which identified individuals with mania in the general population, all found that increased activity and energy was the most commonly endorsed symptom [<a href="#rid21">21,22</a>].</p><p>Manic patients generally have an exaggerated sense of wellbeing and self-confidence, which may extend to grandiosity of psychotic proportions (see <a class="local">'Psychosis'</a> below) [<a href="#rid1">1</a>]. As an example, some patients believe they have a special relationship with God or celebrities, or possess talents that surpass the abilities of others. Among individuals with mania in the general population, increased self-esteem and grandiosity are the least commonly endorsed symptom [<a href="#rid21">21,22</a>], consistent with the lack of insight accompanying manic episodes.</p><p>In addition, mania is almost universally marked by a decreased need for sleep; this is distinguished from insomnia, which involves the inability to sleep despite feeling tired [<a href="#rid1">1</a>]. Manic patients may feel well-rested, or energetic and “wired,” despite sleeping for only a few (eg, three) hours or not all, and patients may not sleep for days without feeling tired [<a href="#rid19">19</a>]. The intensity of this symptom is such that in the premedication era, some patients died from exhaustion.</p><p>Common cognitive symptoms of mania include increased mental activity, racing thoughts, distractibility, and difficulty distinguishing between relevant and irrelevant thoughts [<a href="#rid1">1</a>]. These symptoms result in flight of ideas, which are abrupt changes from one topic to another that are usually based upon understandable associations, but may become severe and cause disorganized thoughts [<a href="#rid23">23</a>]. In addition, some patients do not recall events that occur during manic episodes [<a href="#rid24">24</a>]. Other aspects of cognitive impairment are discussed elsewhere in this topic. (See <a class="local">'Cognition'</a> below.)</p><p>Manic speech is generally loud, pressured or accelerated, difficult to interrupt, and may be accompanied by jokes, singing, clanging (choosing words based upon sounds rather than meaning), and dramatic gesticulations. Irritable patients often make hostile comments, swear more than usual, or launch into angry tirades [<a href="#rid19">19</a>].</p><p>Psychosocial functioning is markedly impaired, and hospitalization is often required to protect manic patients and prevent behavior leading to painful consequences (eg, financial ruin, job loss, divorce, and assaulting others) [<a href="#rid12">12,25</a>]. One impediment to treatment is that many patients, particularly those who are psychotic, have little insight into their psychopathology and functional impairment, and are impervious to feedback from others [<a href="#rid26">26-28</a>].</p><p>An associated feature is that nonpsychotic perception of senses (olfaction, visual acuity, and hearing) is enhanced [<a href="#rid1">1,29</a>].</p><p>The course of illness in mania may be marked by a sudden onset, with rapid progression of episodes over a few days. Alternatively, onset of symptoms and progression from hypomania to mania may be relative slow. The duration of manic episodes ranges from weeks to months; in a prospective observational study of 246 manic episodes, the rate of recovery was such that [<a href="#rid30">30</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>25 percent of the episodes resolved within 4 weeks of onset</p><p class="bulletIndent1"><span class="glyph">●</span>50 percent resolved within 7 weeks</p><p class="bulletIndent1"><span class="glyph">●</span>75 percent resolved within 15 weeks</p><p></p><p>Following recovery from mania, patients typically do not experience residual symptoms.</p><p class="headingAnchor" id="H11685838"><span class="h2">Hypomania</span><span class="headingEndMark"> — </span>Hypomanic episodes  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>) are characterized by changes in mood, energy, activity, behavior, sleep, and cognition that are similar to those of mania, but less severe [<a href="#rid1">1,31</a>]. Examples include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Mood during hypomania can be elevated and euphoric, but patients (especially females) commonly experience irritability, dysphoria, and other co-occurring depressive symptoms. In a prospective cohort of patients with bipolar disorder (n &gt;900), most hypomanic episodes were dysphoric [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Self-esteem may be inflated during hypomania, but never reaches the point of delusional grandiosity that can occur during mania.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although mental overactivity and flight of ideas can occur in either hypomania or mania, thought form is more organized in hypomania.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Thinking in hypomania is often quick and may lead to productive increases in goal-directed activities and enhanced creativity, whereas mania is marked by racing thoughts that are disconnected and lead to aimless, ineffective, or destructive behaviors.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hypomanic speech can be loud and rapid, but typically is easier to interrupt than manic speech.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Psychosocial functioning in hypomania is either improved or mildly impaired, whereas mania markedly impairs functioning.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Risk-taking behavior in hypomania is mild to moderate, but in mania is more severe.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By definition, psychotic symptoms do not occur in hypomania, and hypomania does not necessitate hospitalization. Patients with psychotic features and patients who require hospitalization are classified as manic. (See <a class="local">'Mania'</a> above.)</p><p></p><p>An associated feature of hypomania is that nonpsychotic perception of senses is enhanced [<a href="#rid1">1</a>].</p><p>The course of hypomania is such that it generally begins suddenly and progresses quickly over a few days. Episodes typically resolve within several days to weeks; in a prospective observational study of 126 hypomanic episodes, the rate of recovery was such that [<a href="#rid30">30</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>25 percent of the episodes resolved within two weeks of onset</p><p class="bulletIndent1"><span class="glyph">●</span>50 percent resolved within three weeks</p><p class="bulletIndent1"><span class="glyph">●</span>75 percent resolved within six weeks</p><p></p><p>Hypomanic symptoms in some patients may be more fleeting than manic symptoms. Nevertheless, hypomanic symptoms must be taken seriously because they indicate increasing instability and the need for treatment.</p><p class="headingAnchor" id="H2272752"><span class="h2">Major depression</span><span class="headingEndMark"> — </span>Episodes of major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>) involve clinically significant changes in mood, behavior, energy, sleep, and cognition [<a href="#rid1">1,6</a>]. The intensity of episodes varies widely.</p><p>Similar to unipolar major depression, bipolar major depression is generally characterized by depressed mood, as well as slowing in the pace of mental and physical activity (eg, speech is slow and soft, and output reduced) [<a href="#rid6">6</a>]. Interest or pleasure in usual activities (eg, hobbies) is minimal, energy is low, and memory and concentration are impaired. Appetite is typically diminished and accompanied by weight loss; however, some patients may manifest increased appetite and weight gain. Although behavior is generally slow, some patients are agitated (eg, unable to sit still, wringing their hands, or pacing) [<a href="#rid33">33</a>]. Sleep disturbances (insomnia or hypersomnia) often occur in bipolar depression [<a href="#rid34">34</a>], as do feelings of worthlessness and excessive guilt [<a href="#rid6">6</a>]. Suicidal thoughts and behavior are observed more frequently during major depression than hypomania/mania [<a href="#rid35">35</a>]. (See <a class="local">'Suicide'</a> below.)</p><p>Other clinical features of major depression include poor eye contact, poor hygiene, unkempt appearance, feelings of hopelessness and helplessness, rumination and indecisiveness, negative and nihilistic thoughts, somatic symptoms (eg, pain), and impaired psychosocial functioning [<a href="#rid6">6</a>]. An associated feature is that nonpsychotic perception of senses (eg, olfaction, visual acuity, and hearing) is diminished [<a href="#rid29">29</a>]. Additional information about the clinical manifestation of major depression is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/91774.html" rel="external">"Unipolar depression in adults: Clinical features"</a>.)</p><p>Among patients with bipolar disorder, depressive symptoms occur more often than manic/hypomanic symptoms, especially in bipolar II patients [<a href="#rid36">36,37</a>]. As an example, prospective observational studies examined the mean percent of time that patients had any symptoms of depression or mania/hypomania, including symptoms that met criteria for a mood episode, as well as subthreshold symptoms that did not meet criteria for a full-blown episode. The results included the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar I disorder (n = 146 and 405) [<a href="#rid8">8,38</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Depression was present for 32 and 36 percent of follow-up</p><p class="bulletIndent2"><span class="glyph">•</span>Mania/hypomania was present for 9 and 12 percent of follow-up</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar II disorder (n = 86 and 102) [<a href="#rid9">9,38</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Depression was present for 50 and 36 percent of follow-up</p><p class="bulletIndent2"><span class="glyph">•</span>Hypomania was present for 1 and 10 percent of follow-up</p><p></p><p>For any given patient, the symptom profile of bipolar major depression is often inconsistent across different episodes. A study of 583 patients with at least two prospectively observed depressive episodes found that within an individual patient, there was little consistency in the specific symptoms or sets of symptoms from one episode to the next [<a href="#rid39">39</a>].</p><p>The course of illness in bipolar major depression varies, and onset may be sudden or develop slowly over weeks to months. Episodes typically last several months. A prospective observational study of 373 bipolar major depressive episodes found that the median time to recovery was 15 weeks [<a href="#rid30">30</a>]. In addition, residual symptoms are common among patients who otherwise recover [<a href="#rid8">8,40</a>].</p><p class="headingAnchor" id="H2273002"><span class="h2">Mixed features</span><span class="headingEndMark"> — </span>Bipolar episodes of mania, hypomania, and major depression that are accompanied by symptoms of the opposite polarity are referred to as mood episodes with mixed features (eg, hypomania with mixed features or major depression with mixed features) [<a href="#rid1">1</a>]. Other terms used in the literature include mixed episodes, mixed states, mixed mania/hypomania, mixity, and dysphoric mania/hypomania [<a href="#rid6">6,41,42</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mania/hypomania with mixed features</strong> – Manic or hypomanic episodes with mixed features are characterized by episodes that meet full criteria for mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>) or hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), and at least three of the following depressive symptoms during most days of the episode [<a href="#rid1">1</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Depressed mood</p><p class="bulletIndent2"><span class="glyph">•</span>Diminished interest or pleasure in most activities</p><p class="bulletIndent2"><span class="glyph">•</span>Psychomotor retardation</p><p class="bulletIndent2"><span class="glyph">•</span>Low energy</p><p class="bulletIndent2"><span class="glyph">•</span>Excessive guilt or thoughts of worthlessness</p><p class="bulletIndent2"><span class="glyph">•</span>Recurrent thoughts about death or suicide, or suicide attempt</p><p></p><p class="bulletIndent1">In addition, mania with mixed features is more likely to include clinically significant anxiety or irritability, compared to mania without mixed features [<a href="#rid43">43</a>].</p><p></p><p class="bulletIndent1">Mania/hypomania with mixed features is common. Multiple studies suggest that among patients with mania/hypomania, mixed features are present in approximately 25 to 30 percent [<a href="#rid43">43,44</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Major depression with mixed features</strong> – Bipolar major depressive episodes with mixed features are characterized by episodes that meet full criteria for major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>), and at least three of the following manic/hypomanic symptoms during most days of the episode [<a href="#rid1">1</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elevated or expansive mood</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Inflated self-esteem or grandiosity</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>More talkative than usual or pressured speech</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Flight of ideas (abrupt changes from one topic to another that are based upon understandable associations) or racing thoughts</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Increased energy or goal-directed activity</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Excessive involvement in activities that have a high potential for painful consequences (eg, buying sprees or sexual indiscretions)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Decreased need for sleep</p><p></p><p class="bulletIndent1">Mixed features appear to be common in patients with bipolar major depression. In a prospective study of more than 900 patients with bipolar disorder who were followed for a median of 15 months across more than 14,000 outpatient visits, depression with mixed features was present in 15 percent of the visits [<a href="#rid45">45</a>].</p><p></p><p>Compared to bipolar patients without mixed features, patients with mixed features may be at greater risk for comorbid anxiety disorders and substance use disorders [<a href="#rid42">42</a>]. In addition, response to treatment is often poorer in bipolar mood episodes with mixed features than in pure major depression or pure mania [<a href="#rid30">30,42,46</a>].</p><p>Mood episodes with mixed features may present de novo or develop during episodes of pure mania, pure hypomania, or pure major depression. Following onset of an episode with mixed features, the mixed feature symptoms may be time limited on a given day, and the three symptoms that constitute the mixed features may vary over the illness episode. Bipolar depressive episodes with mixed features can remit entirely or evolve into pure major depression. Mania with mixed features typically does not transition to pure euphoric mania.</p><p>Among patients with bipolar disorder, experiencing mixed features of one polarity appears to increase the risk of mixed features of the opposite polarity. As an example, hypomania with mixed features is more likely to occur in patients who previously had depression with mixed features, compared with patients who have never had depression with mixed features [<a href="#rid45">45</a>].</p><p class="headingAnchor" id="H1673780"><span class="h2">Psychosis</span><span class="headingEndMark"> — </span>Manic, major depressive, and mixed episodes may include psychotic features such as [<a href="#rid1">1,6,47,48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Delusions – False, fixed beliefs that can involve grandiose or persecutory convictions, self-referential themes (events, objects, or people have a special significance for the patient), and less commonly, sexual, religious, or political themes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hallucinations – False sensory perceptions that are typically auditory in nature.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Disorganized thinking and behavior.</p><p></p><p>It appears that psychosis occurs more often during mania than bipolar major depression [<a href="#rid6">6,48,49</a>], and delusions are observed more often than hallucinations [<a href="#rid6">6,48,50</a>]. By definition, hypomania never includes psychotic features [<a href="#rid1">1</a>].</p><p>Psychotic features are common during bipolar mood episodes, such that the lifetime prevalence of psychosis is approximately 60 to 75 percent. A pooled analysis of 33 studies (n &gt;5900 bipolar patients) found a lifetime history of at least one psychotic symptom in 61 percent of patients [<a href="#rid6">6</a>]. Subsequently, a study of bipolar I patients (n &gt;1300) found that the lifetime prevalence of psychotic symptoms was 74 percent [<a href="#rid50">50</a>].</p><p>Within a given patient, psychosis often recurs across different mood episodes [<a href="#rid48">48</a>]. However, it is not clear if psychotic features are associated with a more severe long-term course of illness [<a href="#rid47">47,48,51</a>].</p><p>Additional information about psychosis is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/17193.html" rel="external">"Psychosis in adults: Epidemiology, clinical manifestations, and diagnostic evaluation", section on 'Clinical manifestations'</a>.)</p><p class="headingAnchor" id="H11685859"><span class="h1">COMORBIDITY</span><span class="headingEndMark"> — </span>Most adults with bipolar disorder have at least one comorbid psychiatric or general medical illness, and many patients have multiple co-occurring illnesses [<a href="#rid52">52</a>].</p><p>Comorbidity in pediatric, geriatric, and rapid cycling bipolar disorder is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/15924.html" rel="external">"Pediatric bipolar disorder: Clinical manifestations and course of illness", section on 'Comorbidity'</a> and  <a class="medical medical_review" href="/z/d/html/14650.html" rel="external">"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis", section on 'Comorbidity'</a> and  <a class="medical medical_review" href="/z/d/html/15249.html" rel="external">"Rapid cycling bipolar disorder: Epidemiology, pathogenesis, clinical features, and diagnosis", section on 'Comorbidity'</a>.)</p><p class="headingAnchor" id="H4504471"><span class="h2">Psychiatric disorders</span><span class="headingEndMark"> — </span>Patients with bipolar disorder commonly manifest comorbid psychiatric disorders, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Anxiety disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Attention deficit hyperactivity disorder (ADHD)</p><p class="bulletIndent1"><span class="glyph">●</span>Eating disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Intermittent explosive disorder</p><p class="bulletIndent1"><span class="glyph">●</span>Obsessive-compulsive disorder </p><p class="bulletIndent1"><span class="glyph">●</span>Personality disorders</p><p class="bulletIndent1"><span class="glyph">●</span>Posttraumatic stress disorder (PTSD)</p><p class="bulletIndent1"><span class="glyph">●</span>Substance use disorders</p><p></p><p>The large majority of bipolar patients have at least one other psychiatric disorder. A large, nationally representative survey found that among individuals with bipolar disorder, the lifetime prevalence of at least one co-occurring disorder was 92 percent [<a href="#rid53">53</a>]. By contrast, the lifetime prevalence of at least one psychiatric disorder in the general population was 46 percent [<a href="#rid54">54</a>].</p><p>In addition, many bipolar patients suffer multiple comorbid psychiatric disorders:</p><p class="bulletIndent1"><span class="glyph">●</span>A large, cross-national, epidemiologic survey in 11 countries found that among individuals with bipolar disorder, the lifetime prevalence of three or more comorbid disorders was 44 percent [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An epidemiologic study in the United States found that among individuals with bipolar disorder, the lifetime prevalence of three or more comorbid disorders was 70 percent [<a href="#rid53">53</a>]. By contrast, the lifetime prevalence of three or more psychiatric disorders in the general population was 17 percent [<a href="#rid54">54</a>].</p><p></p><p>Comorbidity is often associated with a worse course of illness in bipolar disorder, including earlier age of onset, more recurrent mood episodes, and more suicide attempts.</p><p class="headingAnchor" id="H4505185"><span class="h3">Anxiety disorders</span><span class="headingEndMark"> — </span>Patients with bipolar disorder frequently suffer comorbid anxiety disorders. As an example, a meta-analysis of 10 community and clinical studies examined the point prevalence of anxiety disorders among individuals with bipolar disorder (n &gt;2100) who were euthymic at the time of assessment [<a href="#rid56">56</a>]. The primary findings included the following:</p><p class="bulletIndent1"><span class="glyph">●</span>At least one anxiety disorder was present in 35 percent of individuals with bipolar disorder.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anxiety disorders occurred five times more often in those with bipolar disorder than population controls (relative risk 5, 95% CI 2-9).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar patients manifested the following anxiety disorders, from most to least common:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Generalized anxiety disorder</p><p class="bulletIndent2"><span class="glyph">•</span>Social anxiety disorder (social phobia)</p><p class="bulletIndent2"><span class="glyph">•</span>Specific phobia</p><p class="bulletIndent2"><span class="glyph">•</span>Agoraphobia</p><p class="bulletIndent2"><span class="glyph">•</span>Panic disorder</p><p></p><p>Compared to bipolar patients without a history of comorbid anxiety disorders, patients with comorbid anxiety have a worse course of illness [<a href="#rid57">57</a>], including:</p><p class="bulletIndent1"><span class="glyph">●</span>Earlier age of onset of bipolar disorder [<a href="#rid58">58,59</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased likelihood of recovery from mood episodes [<a href="#rid57">57,60</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More recurrent mood episodes [<a href="#rid57">57,59-62</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Increased prevalence of substance use disorders [<a href="#rid57">57,58,61</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poorer psychosocial functioning [<a href="#rid60">60,61</a>] and quality of life [<a href="#rid60">60,62</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poorer insight [<a href="#rid57">57</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Greater impulsivity [<a href="#rid63">63,64</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More suicide attempts [<a href="#rid58">58,59,61,62,65-67</a>]</p><p></p><p>The assessment and diagnosis of anxiety disorders are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/496.html" rel="external">"Generalized anxiety disorder in adults: Epidemiology, pathogenesis, clinical manifestations, course, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14628.html" rel="external">"Panic disorder in adults: Epidemiology, clinical manifestations, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15537.html" rel="external">"Social anxiety disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14637.html" rel="external">"Specific phobia in adults: Epidemiology, clinical manifestations, course, and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H1430694219"><span class="h3">Attention deficit hyperactivity disorder</span><span class="headingEndMark"> — </span>Epidemiologic studies show that patients with bipolar disorder often have a history of ADHD:</p><p class="bulletIndent1"><span class="glyph">●</span>A survey in 11 countries found that the lifetime prevalence of ADHD among individuals with bipolar disorder was 20 percent [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study from the United States found that among individuals with bipolar disorder, the lifetime prevalence of ADHD was 31 percent [<a href="#rid53">53</a>]. By contrast, the lifetime prevalence of ADHD in the general population was 8 percent [<a href="#rid54">54</a>].</p><p></p><p>Compared with bipolar patients without a history of comorbid ADHD, patients with comorbid ADHD have a worse course of illness, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Earlier age at onset of bipolar disorder [<a href="#rid68">68-71</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased likelihood of recovery from mood episodes [<a href="#rid68">68</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More recurrent mood episodes [<a href="#rid68">68,69,71</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Increased prevalence of anxiety and substance use disorders [<a href="#rid68">68,70</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poorer psychosocial functioning [<a href="#rid69">69,70</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>History of legal problems and violence [<a href="#rid68">68,71</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More suicide attempts [<a href="#rid68">68</a>]</p><p></p><p>Adult ADHD is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">"Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p class="headingAnchor" id="H564474"><span class="h3">Eating disorders</span><span class="headingEndMark"> — </span>Among patients with bipolar disorders, comorbid eating disorders are common and associated with a worse course of illness.</p><p>In a meta-analysis of 36 studies that included more than 15,000 patients with bipolar disorder, the lifetime prevalence of co-occurring eating disorders was as follows: [<a href="#rid72">72</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Binge-eating disorder – 13 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Bulimia – 7 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Anorexia nervosa – 4 percent</p><p></p><p>However, heterogeneity across studies was large and nearly all the studies were cross-sectional.</p><p>It appears that comorbid eating disorders are observed more often in bipolar patients who are treated in clinical settings, compared with bipolar patients identified in the general population. As an example, a large, nationally representative epidemiologic study of the general population in the United States found that among individuals with bipolar disorder, the estimated lifetime prevalence of binge eating disorder was 3 percent [<a href="#rid73">73</a>].</p><p>Compared with bipolar patients without a history of comorbid eating disorders, patients with comorbid eating disorders have a worse course of illness, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Earlier age of onset of bipolar disorder [<a href="#rid74">74,75</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More recurrent mood episodes [<a href="#rid74">74,75</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Lifetime history of psychosis [<a href="#rid76">76</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Increased prevalence of anxiety and substance use disorders [<a href="#rid74">74-77</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More suicide attempts [<a href="#rid74">74-76</a>]</p><p></p><p>Eating disorders are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2093.html" rel="external">"Eating disorders: Overview of epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2094.html" rel="external">"Eating disorders: Overview of prevention and treatment"</a>.)</p><p class="headingAnchor" id="H20903291"><span class="h3">Intermittent explosive disorder</span><span class="headingEndMark"> — </span>Epidemiologic studies show that in patients with bipolar disorder, approximately 25 to 30 percent suffer comorbid intermittent explosive disorder:</p><p class="bulletIndent1"><span class="glyph">●</span>A survey in 11 countries found that the lifetime prevalence of intermittent explosive disorder among individuals with bipolar disorder was 24 percent [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>One study from the United States found that among individuals with bipolar disorder, the lifetime prevalence of intermittent explosive disorder was 29 percent [<a href="#rid53">53</a>]. By contrast, the lifetime prevalence of intermittent explosive disorder in the general population was 5 percent [<a href="#rid54">54</a>].</p><p></p><p>Intermittent explosive disorder is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/14750.html" rel="external">"Intermittent explosive disorder in adults: Clinical features, assessment, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/16694.html" rel="external">"Intermittent explosive disorder in adults: Treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H3058878425"><span class="h3">Obsessive-compulsive disorder</span><span class="headingEndMark"> — </span>Obsessive-compulsive disorder appears to be more common among individuals with bipolar disorder than the general population. A pooled analysis of 22 community and clinical studies (number of subjects not provided) estimated that the lifetime prevalence of obsessive-compulsive disorder in bipolar disorder was 14 percent [<a href="#rid78">78</a>]; this compares with a prevalence of 2 percent in the United States population. (See  <a class="medical medical_review" href="/z/d/html/498.html" rel="external">"Obsessive-compulsive disorder in adults: Epidemiology, clinical features, and diagnosis", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H6583657"><span class="h3">Personality disorders</span><span class="headingEndMark"> — </span>Personality disorders are more prevalent in bipolar disorder than the general population. A nationally representative survey in the United States found that the one-year prevalence of the following personality disorders was greater among individuals with bipolar disorder than the general population [<a href="#rid79">79</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Any personality disorder – 51 percent of bipolar individuals versus 9 percent of the general population</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Paranoid, schizoid, or schizotypal personality disorder (odd or eccentric cluster) – 13 versus 6 percent</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Antisocial, borderline, histrionic, or narcissistic personality disorder (dramatic, emotional, or erratic cluster) – 15 versus 2 percent</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Avoidant, dependent, obsessive compulsive, or passive aggressive personality disorder (anxious or fearful cluster) – 22 versus 6 percent</p><p></p><p>In addition, personality disorders comorbid with bipolar disorder are common in clinical settings [<a href="#rid80">80</a>]. Multiple studies suggest that among patients with bipolar disorder, the point prevalence of co-occurring personality disorders ranges from approximately 40 to 65 percent:</p><p class="bulletIndent1"><span class="glyph">●</span>A meta-analysis of 13 studies found that in patients with bipolar disorder (n &gt;1100), at least one personality disorder was present in 42 percent [<a href="#rid81">81</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a subsequent study of bipolar patients (n &gt;900), the point prevalence of at least one personality disorder was 66 percent [<a href="#rid82">82</a>].</p><p></p><p>A caveat about diagnosing comorbid personality disorders in a patient with bipolar disorder is that mood symptoms should be fully stabilized before diagnosing a personality disorder. Assessments for personality disorders during a mood episode are associated with substantively greater (inflated) rates of personality disorders [<a href="#rid82">82</a>]. Thus, it is frequently not feasible to diagnose a personality disorder during hospitalization for a bipolar mood episode. The diagnosis of personality disorders is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/6617.html" rel="external">"Overview of personality disorders"</a>.)</p><p>Compared to bipolar patients without a personality disorder, patients with comorbid personality disorders have a worse course of illness, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Earlier age of onset of bipolar disorder [<a href="#rid80">80,82</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased likelihood of recovery from mood episodes [<a href="#rid80">80,83,84</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Greater number of manic episodes [<a href="#rid82">82</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poorer psychosocial functioning [<a href="#rid80">80</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More suicide attempts [<a href="#rid80">80</a>]</p><p></p><p>In addition, personality traits such as novelty seeking and harm avoidance are more common in bipolar patients than healthy controls [<a href="#rid85">85</a>].</p><p class="headingAnchor" id="H188369654"><span class="h4">Borderline personality disorder</span><span class="headingEndMark"> — </span>Multiple studies indicate that among individuals with bipolar disorder, borderline personality disorder is comorbid in approximately 20 percent. In a meta-analysis of 28 hospital-based or population-based studies that included more than 5000 people with bipolar disorder, the prevalence of bipolar disorder was 21.6 percent [<a href="#rid86">86</a>]. However, heterogeneity across studies was large.</p><p>Clinicians can screen for comorbid borderline personality disorder by asking about the affective instability criterion [<a href="#rid87">87</a>].</p><p class="headingAnchor" id="H3839480043"><span class="h3">Posttraumatic stress disorder</span><span class="headingEndMark"> — </span>PTSD commonly co-occurs with bipolar disorder. One literature review noted that the prevalence of comorbid PTSD varies from 4 to 40 percent, and that the prevalence is higher in women than men, and in bipolar I disorder than bipolar II disorder [<a href="#rid88">88</a>]. In addition, the frequency and severity of mood symptoms in patients with bipolar disorder is greater in those with comorbid PTSD than those without PTSD. Comorbid PTSD is also associated with a worse quality of life (subjective satisfaction with one’s physical, psychological, and social functioning).</p><p class="headingAnchor" id="H3048480187"><span class="h3">Substance use disorders</span><span class="headingEndMark"> — </span>Both epidemiologic and clinical studies show that patients with bipolar disorder frequently suffer comorbid substance use disorders, involving drugs such as alcohol, amphetamines, benzodiazepines, cannabis, cocaine, and tobacco [<a href="#rid89">89-91</a>]. Cannabis use may precede or coincide with mania/hypomania, whereas alcohol use may precede or coincide with depression [<a href="#rid92">92,93</a>].</p><p>The lifetime prevalence of comorbid substance-related disorders is approximately 50 percent:</p><p class="bulletIndent1"><span class="glyph">●</span>A survey in 11 countries found that the lifetime prevalence of any substance use disorder among individuals with bipolar I disorder was 52 percent, and in bipolar II disorder was 37 percent [<a href="#rid55">55</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study from the United States found that among individuals with bipolar I disorder, the lifetime prevalence of substance use disorders was 60 percent, and in bipolar II disorder was 40 percent [<a href="#rid53">53</a>]. By contrast, the lifetime prevalence of substance use disorders in the United States general population was 15 percent [<a href="#rid54">54</a>].</p><p></p><p>Studies of bipolar patients in clinical settings indicate that comorbid alcohol and drug use disorders are associated with a worse course of illness, including [<a href="#rid94">94-96</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>More mood symptoms [<a href="#rid97">97-99</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More hospitalizations [<a href="#rid100">100,101</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased likelihood of recovery from mood episodes [<a href="#rid98">98,102,103</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More recurrent mood episodes [<a href="#rid90">90,94,103,104</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Neurocognitive impairment [<a href="#rid105">105</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poorer psychosocial functioning [<a href="#rid102">102,106</a>] and quality of life [<a href="#rid107">107,108</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Higher levels of aggressiveness [<a href="#rid94">94,109</a>] and more arrests [<a href="#rid104">104,110</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More suicide attempts [<a href="#rid102">102,111-114</a>]</p><p></p><p>In addition, comorbid substance use disorders are associated with decreased adherence to treatment for bipolar disorder, which may in part explain the worse course of illness [<a href="#rid115">115,116</a>].</p><p>The assessment, diagnosis, and treatment of substance use disorders are discussed separately.</p><p class="headingAnchor" id="H4504502"><span class="h2">General medical illnesses</span><span class="headingEndMark"> — </span>Bipolar disorder is associated with an increased risk for comorbid general medical illnesses [<a href="#rid117">117,118</a>], and most patients who present in clinical settings have one or more medical conditions. A study from the Systematic Treatment Enhancement Program for Bipolar Disorder found that among more than 3700 bipolar patients, at least one comorbid medical illness was observed in 59 percent [<a href="#rid119">119</a>]. In other clinical studies of bipolar disorder, the mean number of co-occurring general medical illnesses ranged from 2.4 to 3.4 [<a href="#rid107">107,120-122</a>]. The number and severity of general medical illnesses may increase with age and duration of bipolar disorder [<a href="#rid122">122</a>].</p><p>In addition, medical comorbidity is common among the general population of people with bipolar disorder. A nationally representative epidemiologic study found that the prevalence of at least one general medical condition in the past year among individuals with bipolar disorder (n &gt;1500) was 32 percent, and the prevalence of five or more conditions was 10 percent [<a href="#rid123">123</a>].</p><p>General medical disorders that appear to be more prevalent among bipolar patients than persons without the disorder include the following [<a href="#rid117">117,118,120,124-131</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Relatively common among bipolar patients [<a href="#rid117">117</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Arthritis (eg, rheumatoid arthritis or osteoarthritis)</p><p class="bulletIndent2"><span class="glyph">•</span>Asthma</p><p class="bulletIndent2"><span class="glyph">•</span>Cardiovascular disease (angina pectoris, dyslipidemia, hypertension, myocardial infarction, or stroke)</p><p class="bulletIndent2"><span class="glyph">•</span>Headache (eg, migraine)</p><p class="bulletIndent2"><span class="glyph">•</span>Thyroid disease (hyperthyroidism or hypothyroidism)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Less common:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cancer</p><p class="bulletIndent2"><span class="glyph">•</span>Chronic obstructive pulmonary disease</p><p class="bulletIndent2"><span class="glyph">•</span>Diabetes</p><p class="bulletIndent2"><span class="glyph">•</span>Epilepsy</p><p class="bulletIndent2"><span class="glyph">•</span>Gastritis and stomach ulcer</p><p class="bulletIndent2"><span class="glyph">•</span>HIV infection</p><p class="bulletIndent2"><span class="glyph">•</span>Kidney disease</p><p class="bulletIndent2"><span class="glyph">•</span>Liver disease other than cirrhosis (eg, hepatitis C)</p><p class="bulletIndent2"><span class="glyph">•</span>Metabolic syndrome and obesity</p><p class="bulletIndent2"><span class="glyph">•</span>Pain (chronic)</p><p class="bulletIndent2"><span class="glyph">•</span>Parkinson disease</p><p class="bulletIndent2"><span class="glyph">•</span>Vitamin D deficiency</p><p></p><p>Compared to bipolar patients without a history of comorbid general medical conditions, patients with co-occurring conditions have a worse course of illness, including:</p><p class="bulletIndent1"><span class="glyph">●</span>Decreased probability of recovery from depressive episodes [<a href="#rid126">126</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More recurrent mood episodes [<a href="#rid123">123,132-134</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Increased prevalence of anxiety and substance use disorders [<a href="#rid123">123,126,134-137</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Poorer psychosocial functioning [<a href="#rid123">123,126,136</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>More suicide attempts [<a href="#rid137">137,138</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Increased all-cause mortality (see <a class="local">'Mortality'</a> below)</p><p></p><p class="headingAnchor" id="H4504461"><span class="h1">COGNITION</span><span class="headingEndMark"> — </span>Intelligence quotient (IQ) appears to be largely preserved in bipolar disorder [<a href="#rid139">139-141</a>]. However, many patients manifest deficits in other aspects of cognition, including neurocognitive functioning and social cognition. Cognitive impairments may stem from the primary bipolar disorder or other etiologies such as medications (eg, antipsychotics), comorbidities such as attention deficit hyperactivity disorder or substance use disorders, or physical inactivity [<a href="#rid142">142-144</a>].</p><p class="headingAnchor" id="H3306884421"><span class="h2">Neurocognitive functioning</span><span class="headingEndMark"> — </span>Multiple studies using standardized tests consistently demonstrate that neuropsychological function in patients with bipolar disorder is often impaired during euthymia as well as mood episodes [<a href="#rid139">139,145-148</a>]. As an example, a meta-analysis of 45 observational studies compared 1423 euthymic bipolar patients with 1524 healthy controls, and found several deficits in patients, including impaired [<a href="#rid149">149</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Attention</p><p class="bulletIndent1"><span class="glyph">●</span>Verbal memory</p><p class="bulletIndent1"><span class="glyph">●</span>Executive function (eg, planning, concept or set shifting, and response inhibition)</p><p class="bulletIndent1"><span class="glyph">●</span>Information processing speed</p><p></p><p>A subsequent meta-analysis of individual patient data (31 studies, 2876 euthymic bipolar patients and healthy controls) that controlled for age, sex, and IQ found that these deficits were clinically small to moderate [<a href="#rid150">150</a>].</p><p>However, across different patients with bipolar disorder, neurocognitive function is heterogeneous and ranges from normal to global impairment [<a href="#rid143">143,151</a>]. It is estimated that the type and prevalence of impairment is as follows [<a href="#rid142">142,152</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cognitively intact (little to no impairment) – 30 to 50 percent of patients</p><p class="bulletIndent1"><span class="glyph">●</span>Selective deficits (eg, attention and processing speed) – 30 to 40 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Broad-based deficits (most or all domains) – 10 to 40 percent</p><p></p><p>Neuropsychological impairment in bipolar disorder is apparent following the first manic episode (but not prior to onset of the disorder) [<a href="#rid143">143,153</a>]. The deficits persist over time and remain stable (rather than progressing) [<a href="#rid154">154-159</a>], are associated with impaired psychosocial functioning and quality of life [<a href="#rid142">142,152,160,161</a>], and overlap with impairments found in schizophrenia and schizoaffective disorder [<a href="#rid162">162-165</a>] as well as unipolar major depression [<a href="#rid140">140,166</a>].</p><p>Cognitive impairment in pediatric and geriatric bipolar disorder is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/15924.html" rel="external">"Pediatric bipolar disorder: Clinical manifestations and course of illness", section on 'Cognitive impairment'</a> and  <a class="medical medical_review" href="/z/d/html/14650.html" rel="external">"Geriatric bipolar disorder: Epidemiology, clinical features, assessment, and diagnosis", section on 'Cognitive impairment'</a>.)</p><p class="headingAnchor" id="H1673633"><span class="h2">Social cognition</span><span class="headingEndMark"> — </span>In some patients, bipolar disorder is associated with impaired social cognition or competence [<a href="#rid152">152,167-169</a>]. Social cognition involves the ability to:</p><p class="bulletIndent1"><span class="glyph">●</span>Recognize or infer thoughts, beliefs, and intentions in oneself and others – This knowledge of one’s own mind and that of others is often referred to as “theory of mind.”</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Identify basic emotions such as happiness, sadness, fear, anger, disgust, and surprise in others (emotion processing or facial expression recognition).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Make decisions by weighing choices associated with variable rewards and punishments.</p><p></p><p>A meta-analysis of 20 observational studies (650 euthymic bipolar patients and 607 healthy controls) [<a href="#rid167">167</a>], and a subsequent meta-analysis (18 studies, 1020 patients and controls) [<a href="#rid170">170</a>], found statistically significant, clinically moderate to large deficits in theory of mind, as well as clinically small to moderate impairments in facial emotion recognition [<a href="#rid167">167</a>].</p><p class="headingAnchor" id="H17399255"><span class="h2">Creativity</span><span class="headingEndMark"> — </span>The hypothesis that bipolar disorder is associated with creativity is longstanding but not established [<a href="#rid6">6,171,172</a>]. Limited evidence for the association includes studies that found higher scores on creativity measures in bipolar patients than controls, and disproportionately high rates of bipolar disorder in creative individuals or occupations [<a href="#rid173">173-176</a>]. As an example, case control studies based upon national registries identified bipolar patients, healthy siblings of patients, and controls; the results showed that:</p><p class="bulletIndent1"><span class="glyph">●</span>University students who studied artistically creative subjects (eg, visual arts, music, or dance) were more likely to eventually develop bipolar disorder, compared with the healthy siblings (odds ratio 1.3, 95% CI 1.1-1.5) and the general population (odds ratio 1.6, 95% CI 1.5-1.8) [<a href="#rid177">177</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar patients were more likely to have worked in creative professions than controls (odds ratio 1.4, 95% CI 1.2-1.5), and siblings were also more likely to have worked in creative professions than controls (odds ratio 1.3, 95% CI 1.2-1.5) [<a href="#rid178">178</a>].</p><p></p><p>In addition, a population-based study found that the genetic risk for bipolar disorder (based upon multiple genetic markers from genome-wide association data) was greater among creative individuals (eg, actors, dancers, and musicians) than other individuals in the sample, suggesting that the genetic predisposition for bipolar disorder and for creativity may overlap with each other [<a href="#rid179">179,180</a>]. A review hypothesized that one reason the bipolar phenotype persists, despite increased impairment and mortality (see <a class="local">'Mortality'</a> below), is that bipolar disorder and creativity share genetic factors, which confer an evolutionary advantage to relatives of bipolar patients who are unaffected or do not develop the full illness [<a href="#rid181">181</a>].</p><p class="headingAnchor" id="H3298779186"><span class="h1">LEGAL PROBLEMS</span><span class="headingEndMark"> — </span>Most patients with bipolar disorder incur criminal justice problems [<a href="#rid182">182</a>]. In a nationally representative survey in the United States [<a href="#rid183">183</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The lifetime prevalence of criminal behavior among individuals with bipolar disorder was 69 percent. After adjusting for potential confounding factors (sex, education, and other psychiatric disorders), the analyses found that individuals with bipolar disorder were more than twice as likely to engage in criminal behavior than individuals with no psychiatric disorder (odds ratio 2.2, 95% CI 1.7-2.8).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The lifetime prevalence of incarceration among individuals with bipolar disorder was 31 percent. After adjusting for potential confounding factors, the analyses found that the risk of incarceration was one and a half times more likely in those with bipolar disorder than individuals with no psychiatric disorder (odds ratio 1.5, 95% CI 1.1-1.9).</p><p></p><p>One hypothesis is that incarceration and other legal problems increase as the number of psychiatric hospital beds decreases [<a href="#rid184">184</a>].</p><p class="headingAnchor" id="H9947133"><span class="h1">VIOLENCE</span><span class="headingEndMark"> — </span>Patients with bipolar disorder appear to be at an increased risk of being victimized by violence, compared with the general population [<a href="#rid185">185</a>]. However, it is not known if bipolar disorder is associated with an increased risk of perpetrating of violence due to inconsistent results across different studies [<a href="#rid186">186</a>]. Nevertheless, it appears that there is a greater risk that patients will be targets of violence, rather than perpetrators [<a href="#rid187">187,188</a>]. In addition, victimization and perpetration may be related to each other, and patients may exhibit both.</p><p class="headingAnchor" id="H3092417351"><span class="h2">Victimization</span><span class="headingEndMark"> — </span>A pooled analysis of three observational studies (n = 428 bipolar patients) found that the six-month prevalence of violence victimization was 38 percent [<a href="#rid189">189</a>]. In addition, multiple national registries suggest that after adjusting for potential confounding factors, individuals with bipolar disorder are subjected to violent crime more often than the population without mental disorders [<a href="#rid185">185</a>]. As an example, analyses in one such study found that after controlling for age, sex, and comorbid psychiatric disorders, subjection to violence was three times greater in bipolar patients, compared with their own biologic siblings without psychiatric disorders (hazard ratio 3, 95% CI 2-4) [<a href="#rid190">190</a>].</p><p>Patients with bipolar disorder may be the target of violence due to homelessness and comorbid substance use disorders [<a href="#rid188">188</a>]. In addition, untreated symptoms such as psychotic features may provoke violence from others.</p><p class="headingAnchor" id="H17398905"><span class="h2">Perpetration</span><span class="headingEndMark"> — </span>Based upon a meta-analysis of 12 studies, it is estimated that the prevalence of violent criminal behavior in patients with bipolar disorder is 7 percent [<a href="#rid186">186</a>]. However, it is not clear whether patients are more likely to perpetrate violence than the general population, due to differences in methods and results across studies:</p><p class="bulletIndent1"><span class="glyph">●</span>Investigators who performed a meta-analysis of 12 studies, which included patients with bipolar disorder (n &gt;58,000) and general population controls (nearly 9 million), concluded that bipolar disorder was not associated with an increased risk of violent criminal behavior [<a href="#rid186">186</a>]. The meta-analysis found that violent criminal behavior was five times more likely in bipolar patients than the general population (odds ratio 5.2, 95% CI 1.3-20.3). However, the comparator group in one of the studies did not have any violent criminal behavior, which led to a very large odds ratio for that study and likely biased the results of the meta-analysis. When that study was removed in a sensitivity analysis that included the other 11 studies (n &gt;58,000 bipolar patients), the association between bipolar disorder and violent criminal behavior was no longer statistically significant (odds ratio 2.8, 95% CI 0.7-11.3).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>By contrast, other investigators assert that perpetration of violence is greater among bipolar patients than the general population [<a href="#rid188">188,191</a>]. Evidence that supports this hypothesis includes a national registry study of patients with bipolar disorder (n &gt;17,000) and their full biologic siblings without psychiatric disorders; after adjusting for potential confounding factors (eg, age, sex, and comorbid psychiatric disorders), the analyses showed that perpetration of violence was three times greater in patients than the siblings (hazard ratio 3, 95% CI 2-4) [<a href="#rid190">190</a>]. Potential triggers for violent criminality include exposure to violence, substance intoxication, and traumatic brain injury [<a href="#rid192">192</a>].</p><p></p><p>In a meta-analysis of nine studies that compared bipolar patients and patients with other psychiatric disorders, the risk of violent criminal behavior in the two groups was comparable (odds ratio 0.8, 95% CI 0.4-1.4) [<a href="#rid186">186</a>].</p><p>Assessment and management of violent behavior are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/291.html" rel="external">"Assessment and emergency management of the acutely agitated or violent adult"</a>.)</p><p class="headingAnchor" id="H1545322047"><span class="h1">MORTALITY</span><span class="headingEndMark"> — </span>All-cause mortality is increased in bipolar disorder. As an example, national registry studies have found that:</p><p class="bulletIndent1"><span class="glyph">●</span>Life expectancy was approximately nine years shorter in bipolar patients (n &gt;6600) than the general population [<a href="#rid193">193</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bipolar disorder was associated with a standardized mortality ratio (number of observed deaths divided by the number of expected deaths) of 3 [<a href="#rid194">194</a>].</p><p></p><p class="headingAnchor" id="H3395833955"><span class="h2">Natural causes</span><span class="headingEndMark"> — </span>In a national registry study, premature mortality in bipolar disorder was related to a two- to three-fold increase in deaths due to coronary heart disease, chronic obstructive pulmonary disease, diabetes mellitus, and influenza or pneumonia [<a href="#rid193">193</a>]. However, mortality from chronic diseases (coronary heart disease, chronic obstructive pulmonary disorder, and diabetes) was lower for bipolar patients who were previously diagnosed with chronic disease than bipolar patients without a prior diagnosis. Thus, identifying and treating chronic diseases in bipolar patients may reduce premature mortality.</p><p class="headingAnchor" id="H436492995"><span class="h2">Suicide</span></p><p class="headingAnchor" id="H3748673372"><span class="h3">Attempts</span><span class="headingEndMark"> — </span>Suicide attempts are common in bipolar disorder. One review that included 26 prospective studies, with follow-up ranging from 1.5 to 44 years, found that suicide attempts occurred in approximately 20 percent of patients [<a href="#rid195">195</a>]. In addition, a study prospectively followed bipolar patients for an average of 16 months, and observed that among 174 patients who attempted suicide, multiple attempts occurred in 32 percent [<a href="#rid196">196</a>].</p><p>Literature reviews have found many factors in patients with bipolar disorder that are associated with an increased risk of suicide attempts [<a href="#rid197">197,198</a>]. However, these risk factors are often not consistently associated with attempting suicide across multiple studies, and are likely to have limited predictive power for any specific patient. The following characteristics may have some utility in identifying bipolar patients who are at increased risk of attempting suicide, because the association between the characteristic and attempted suicide is based upon meta-analyses of three or more studies that compared patients who attempted suicide and those who did not:</p><p class="bulletIndent1"><span class="glyph">●</span>Sociodemographic: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Female gender [<a href="#rid199">199</a>]</p><p class="bulletIndent2"><span class="glyph">•</span>Never married (single) [<a href="#rid65">65</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Clinical:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Depressive mood episode [<a href="#rid35">35,199,200</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Comorbid psychiatric disorders:</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Anxiety disorder [<a href="#rid65">65,199</a>]</p><p class="bulletIndent3"><span class="glyph">-</span>Substance use disorder (eg, alcohol) [<a href="#rid65">65,199</a>]</p><p class="bulletIndent3"><span class="glyph">-</span>Borderline personality disorder [<a href="#rid199">199</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Rapid cycling [<a href="#rid65">65</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>First degree family history of suicide death [<a href="#rid65">65,199</a>]</p><p></p><p>The meta-analyses found that the likelihood of suicide attempts was greatest in bipolar patients with a depressive mood episode (odds ratio 6) and comorbid borderline personality disorder (odds ratio 3) [<a href="#rid199">199</a>].</p><p>In other studies, increased severity of depressive symptoms was associated with increased intent of suicide or frequency of suicide attempts, regardless of mood episode type such as bipolar depression or bipolar depression with mixed features [<a href="#rid35">35,200</a>].</p><p>Other risk factors for suicide attempts in bipolar disorder that have been observed in multiple studies include a history of prior suicide attempt [<a href="#rid198">198</a>], and a history of trauma, such as physical or sexual abuse [<a href="#rid65">65,198,201</a>].</p><p>Although younger age of onset of bipolar disorder is repeatedly mentioned as a risk factor for suicide attempts [<a href="#rid197">197,198</a>], its clinical utility is limited because the mean difference between patients who have attempted suicide and those who have not is only three years [<a href="#rid65">65,199</a>].</p><p>Additional information about suicidal ideation and behavior is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1708.html" rel="external">"Suicidal ideation and behavior in adults"</a>.)</p><p class="headingAnchor" id="H1692344552"><span class="h3">Deaths</span><span class="headingEndMark"> — </span>Reviews estimate that approximately 10 to 20 percent of bipolar patients die by suicide [<a href="#rid197">197,202</a>]. In addition, multiple studies indicate that the rate of suicide deaths is greater in patients than the general population [<a href="#rid195">195,197,203,204</a>]. As an example, a national registry study examined mortality from suicide in more than six million adults, including patients with bipolar disorder (n &gt;6600) [<a href="#rid193">193</a>]. After adjusting for potential covariates (eg, age, marital status, and substance use disorders), the analyses found that the risk of suicide was approximately five times greater in men with bipolar disorder than other men, and about five times greater in women with bipolar disorder than other women.</p><p>The following risk factors may have some utility in identifying bipolar patients who are at increased risk of suicide death, based upon meta-analyses of four or more studies that compared patients who died by suicide and those who did not:</p><p class="bulletIndent1"><span class="glyph">●</span>Male gender (odds ratio 1.5 and 1.8) [<a href="#rid65">65,199</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>History of attempted suicide (odds ratio 2.3) [<a href="#rid65">65</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>First degree family history of suicide death (odds ratio 2.6 and 2.9) [<a href="#rid65">65,199</a>]</p><p></p><p>Other risk factors for suicide in bipolar disorder that have been observed in multiple studies include hopelessness [<a href="#rid65">65</a>], depressive mood episodes [<a href="#rid197">197,198</a>], and mixed features [<a href="#rid197">197,198</a>].</p><p class="headingAnchor" id="H517039"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, “The Basics” and “Beyond the Basics.” The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on “patient info” and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15348.html" rel="external">"Patient education: Bipolar disorder (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/4869.html" rel="external">"Patient education: Bipolar disorder (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H2518726503"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosing bipolar disorder</strong> – Diagnosis of bipolar mood episodes and disorders is generally made according to the American Psychiatric Association's Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). (See  <a class="medical medical_review" href="/z/d/html/86602.html" rel="external">"Bipolar disorder in adults: Assessment and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation of bipolar disorder</strong> – Bipolar disorder can present with mania  (<a class="graphic graphic_table graphicRef91106" href="/z/d/graphic/91106.html" rel="external">table 1</a>), hypomania  (<a class="graphic graphic_table graphicRef91107" href="/z/d/graphic/91107.html" rel="external">table 2</a>), or major depression  (<a class="graphic graphic_table graphicRef91398" href="/z/d/graphic/91398.html" rel="external">table 3</a>). The mood episode at onset of bipolar disorder is usually major depression. (See <a class="local">'Overview'</a> above and <a class="local">'Mania'</a> above and <a class="local">'Hypomania'</a> above and <a class="local">'Major depression'</a> above.)</p><p></p><p class="bulletIndent1">Mania and bipolar major depression are often accompanied by psychotic features, such as delusions (false, fixed beliefs) and hallucinations (false sensory perceptions); by definition, psychosis does not occur in hypomania. (See <a class="local">'Psychosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Comorbidity</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Psychiatric</strong> – Most patients with bipolar disorder have at least one comorbid psychiatric illness; common co-occurring disorders include (see <a class="local">'Psychiatric disorders'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Anxiety disorders</p><p class="bulletIndent3"><span class="glyph">-</span>Attention deficit hyperactivity disorder</p><p class="bulletIndent3"><span class="glyph">-</span>Eating disorders</p><p class="bulletIndent3"><span class="glyph">-</span>Intermittent explosive disorder</p><p class="bulletIndent3"><span class="glyph">-</span>Obsessive-compulsive disorder</p><p class="bulletIndent3"><span class="glyph">-</span>Personality disorders</p><p class="bulletIndent3"><span class="glyph">-</span>Posttraumatic stress disorder</p><p class="bulletIndent3"><span class="glyph">-</span>Substance use disorders</p><p></p><p class="bulletIndent2">(See <a class="local">'Psychiatric disorders'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>General medical illnesses</strong> – Patients with bipolar disorder are also at increased risk for comorbid general medical illnesses. (See <a class="local">'General medical illnesses'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurocognitive function</strong> – Multiple studies using standardized tests in bipolar patients demonstrate that neurocognitive function is generally impaired during asymptomatic phases as well as mood episodes; deficits include impaired attention, verbal memory, executive function, and information processing speed. (See <a class="local">'Cognition'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Violence</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Victimization</strong> – Patients with bipolar disorder appear to be at an increased risk of being victimized by violence, compared with the general population. Also, patients may be victims of violence at rates that are greater than the rate at which they perpetrate violence. (See <a class="local">'Victimization'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Perpetration </strong>– It is not known if the risk of perpetrating violence is greater in bipolar disorder than the general population, due to inconsistent results across different studies. Aggressive behavior in bipolar disorder and in other psychiatric disorders appears to be comparable. (See <a class="local">'Perpetration'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Suicide</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Attempts</strong> – Suicide attempts are common in bipolar disorder and associated with marital status of never married (single), history of physical or sexual abuse, depressive symptoms, mixed states, progressive severity of depressive episodes, comorbid psychiatric disorders, and family history of suicide death. (See <a class="local">'Attempts'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Deaths</strong> – Approximately 10 to 20 percent of bipolar patients die by suicide, which is greater than the rate of suicide in the general population. Risk factors for completed suicide include hopelessness and a history of attempted suicide. (See <a class="local">'Deaths'</a> above.)</p><p></p><p class="headingAnchor" id="H2878111704"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Victoria Cosgrove, PhD, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</li><li><a class="nounderline abstract_t">GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017; 390:1211.</a></li><li><a class="nounderline abstract_t">Dagani J, Signorini G, Nielssen O, et al. Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder. Can J Psychiatry 2017; 62:247.</a></li><li class="breakAll">International Classification of Diseases 11th Revision. Mental, behavioural or neurodevelopmental disorders. Mood disorders. Bipolar or related disorders. https://www.who.int/classifications/classification-of-diseases (Accessed on June 01, 2022).</li><li><a class="nounderline abstract_t">Vinberg M, Mikkelsen RL, Kirkegaard T, et al. Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study. J Affect Disord 2017; 208:521.</a></li><li class="breakAll">Goodwin FK, Jamison KR. Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression, 2nd edition, Oxford University Press, New York 2007.</li><li><a class="nounderline abstract_t">Sylvia LG, Dupuy JM, Ostacher MJ, et al. Sleep disturbance in euthymic bipolar patients. J Psychopharmacol 2012; 26:1108.</a></li><li><a class="nounderline abstract_t">Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59:530.</a></li><li><a class="nounderline abstract_t">Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003; 60:261.</a></li><li><a class="nounderline abstract_t">Perlis RH, Ostacher MJ, Goldberg JF, et al. Transition to mania during treatment of bipolar depression. Neuropsychopharmacology 2010; 35:2545.</a></li><li><a class="nounderline abstract_t">Baldessarini RJ, Tondo L, Visioli C. First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand 2014; 129:383.</a></li><li><a class="nounderline abstract_t">Kupfer DJ, Frank E, Grochocinski VJ, et al. Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry 2002; 63:120.</a></li><li><a class="nounderline abstract_t">Skjelstad DV, Malt UF, Holte A. Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review. J Affect Disord 2010; 126:1.</a></li><li><a class="nounderline abstract_t">Howes OD, Lim S, Theologos G, et al. A comprehensive review and model of putative prodromal features of bipolar affective disorder. Psychol Med 2011; 41:1567.</a></li><li><a class="nounderline abstract_t">Bauer M, Juckel G, Correll CU, et al. Diagnosis and treatment in the early illness phase of bipolar disorders. Eur Arch Psychiatry Clin Neurosci 2008; 258 Suppl 5:50.</a></li><li><a class="nounderline abstract_t">Faedda GL, Baldessarini RJ, Marangoni C, et al. An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder. Bipolar Disord 2019; 21:720.</a></li><li><a class="nounderline abstract_t">Vieta E, Salagre E, Grande I, et al. Early Intervention in Bipolar Disorder. Am J Psychiatry 2018; 175:411.</a></li><li><a class="nounderline abstract_t">McGrath JJ, Saha S, Al-Hamzawi A, et al. The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders. Am J Psychiatry 2016; 173:997.</a></li><li><a class="nounderline abstract_t">Mitchell PB, Loo CK, Gould BM. Diagnosis and monitoring of bipolar disorder in general practice. Med J Aust 2010; 193:S10.</a></li><li><a class="nounderline abstract_t">Mathias de Almeida K, Nery FG, Moreno RA, et al. A sib-pair analysis of impulsivity in bipolar disorder type I. Compr Psychiatry 2013; 54:1148.</a></li><li><a class="nounderline abstract_t">Agrawal A, Nurnberger JI Jr, Lynskey MT. Item response modeling of DSM-IV mania symptoms in two representative US epidemiological samples. Psychol Med 2010; 40:1549.</a></li><li><a class="nounderline abstract_t">Carragher N, Weinstock LM, Strong D. Psychometric evaluation of the DSM-IV criterion B mania symptoms in an Australian national sample. Psychol Med 2013; 43:433.</a></li><li class="breakAll">Shahrokh NC, Hales RE, Phillips KA, Yudofsky SC. The Language of Mental Health: A Glosary of Psychiatric Terms, American Psychiatric Publishing, Inc., Washington, DC 2011. p.107.</li><li><a class="nounderline abstract_t">King MJ, MacDougall AG, Ferris S, et al. Impaired episodic memory for events encoded during mania in patients with bipolar disorder. Psychiatry Res 2013; 205:213.</a></li><li><a class="nounderline abstract_t">Peele PB, Xu Y, Kupfer DJ. Insurance expenditures on bipolar disorder: clinical and parity implications. Am J Psychiatry 2003; 160:1286.</a></li><li><a class="nounderline abstract_t">Ghaemi SN, Stoll AL, Pope HG Jr. Lack of insight in bipolar disorder. The acute manic episode. J Nerv Ment Dis 1995; 183:464.</a></li><li><a class="nounderline abstract_t">Dell'Osso L, Pini S, Cassano GB, et al. Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features. Bipolar Disord 2002; 4:315.</a></li><li><a class="nounderline abstract_t">Pini S, Cassano GB, Dell'Osso L, Amador XF. Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry 2001; 158:122.</a></li><li><a class="nounderline abstract_t">Parker G, Paterson A, Romano M, Graham R. Altered Sensory Phenomena Experienced in Bipolar Disorder. Am J Psychiatry 2017; 174:1146.</a></li><li><a class="nounderline abstract_t">Solomon DA, Leon AC, Coryell WH, et al. Longitudinal course of bipolar I disorder: duration of mood episodes. Arch Gen Psychiatry 2010; 67:339.</a></li><li><a class="nounderline abstract_t">Benazzi F. Bipolar disorder--focus on bipolar II disorder and mixed depression. Lancet 2007; 369:935.</a></li><li><a class="nounderline abstract_t">Suppes T, Mintz J, McElroy SL, et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon. Arch Gen Psychiatry 2005; 62:1089.</a></li><li><a class="nounderline abstract_t">Serra F, Gordon-Smith K, Perry A, et al. Agitated depression in bipolar disorder. Bipolar Disord 2019; 21:547.</a></li><li><a class="nounderline abstract_t">Grigolon RB, Trevizol AP, Cerqueira RO, et al. Hypersomnia and Bipolar Disorder: A systematic review and meta-analysis of proportion. J Affect Disord 2019; 246:659.</a></li><li><a class="nounderline abstract_t">Fiedorowicz JG, Persons JE, Assari S, et al. Depressive symptoms carry an increased risk for suicidal ideation and behavior in bipolar disorder without any additional contribution of mixed symptoms. J Affect Disord 2019; 246:775.</a></li><li><a class="nounderline abstract_t">Post RM, Leverich GS, Nolen WA, et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network. Bipolar Disord 2003; 5:396.</a></li><li><a class="nounderline abstract_t">De Dios C, Ezquiaga E, Garcia A, et al. Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: a prospective, 18-month follow-up study. J Affect Disord 2010; 125:74.</a></li><li><a class="nounderline abstract_t">Kupka RW, Altshuler LL, Nolen WA, et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007; 9:531.</a></li><li><a class="nounderline abstract_t">Perlis RH, Ostacher MJ, Uher R, et al. Stability of symptoms across major depressive episodes in bipolar disorder. Bipolar Disord 2009; 11:867.</a></li><li><a class="nounderline abstract_t">Post RM, Denicoff KD, Leverich GS, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003; 64:680.</a></li><li><a class="nounderline abstract_t">Azorin JM, Baraille L, Gérard S, et al. Mixed states with predominant manic or depressive symptoms: baseline characteristics and 24-month outcomes of the EMBLEM cohort. J Affect Disord 2013; 146:369.</a></li><li><a class="nounderline abstract_t">Swann AC, Lafer B, Perugi G, et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry 2013; 170:31.</a></li><li><a class="nounderline abstract_t">Suppes T, Eberhard J, Lemming O, et al. Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials. Int J Bipolar Disord 2017; 5:36.</a></li><li><a class="nounderline abstract_t">Na KS, Kang JM, Cho SE. Prevalence of DSM-5 mixed features: A meta-analysis and systematic review. J Affect Disord 2021; 282:203.</a></li><li><a class="nounderline abstract_t">Miller S, Suppes T, Mintz J, et al. Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network. Am J Psychiatry 2016; 173:1015.</a></li><li><a class="nounderline abstract_t">McElroy SL, Keck PE Jr, Pope HG Jr, et al. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry 1992; 149:1633.</a></li><li><a class="nounderline abstract_t">Ostergaard SD, Bertelsen A, Nielsen J, et al. The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder. J Affect Disord 2013; 147:44.</a></li><li><a class="nounderline abstract_t">Smith LM, Johns LC, Mitchell R. Characterizing the experience of auditory verbal hallucinations and accompanying delusions in individuals with a diagnosis of bipolar disorder: A systematic review. Bipolar Disord 2017; 19:417.</a></li><li><a class="nounderline abstract_t">Dell'Osso L, Pini S, Tundo A, et al. Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features. Compr Psychiatry 2000; 41:242.</a></li><li><a class="nounderline abstract_t">van Bergen AH, Verkooijen S, Vreeker A, et al. The characteristics of psychotic features in bipolar disorder. Psychol Med 2019; 49:2036.</a></li><li><a class="nounderline abstract_t">Burton CZ, Ryan KA, Kamali M, et al. Psychosis in bipolar disorder: Does it represent a more "severe" illness? Bipolar Disord 2018; 20:18.</a></li><li><a class="nounderline abstract_t">McElroy SL, Altshuler LL, Suppes T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001; 158:420.</a></li><li><a class="nounderline abstract_t">Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007; 64:543.</a></li><li><a class="nounderline abstract_t">Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:593.</a></li><li><a class="nounderline abstract_t">Merikangas KR, Jin R, He JP, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68:241.</a></li><li><a class="nounderline abstract_t">Pavlova B, Perlis RH, Mantere O, et al. Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis. Psychol Med 2017; 47:1107.</a></li><li><a class="nounderline abstract_t">McIntyre RS, Soczynska JK, Bottas A, et al. Anxiety disorders and bipolar disorder: a review. Bipolar Disord 2006; 8:665.</a></li><li><a class="nounderline abstract_t">Simon NM, Otto MW, Wisniewski SR, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2004; 161:2222.</a></li><li><a class="nounderline abstract_t">Goes FS, McCusker MG, Bienvenu OJ, et al. Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med 2012; 42:1449.</a></li><li><a class="nounderline abstract_t">Otto MW, Simon NM, Wisniewski SR, et al. Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 2006; 189:20.</a></li><li><a class="nounderline abstract_t">Sala R, Goldstein BI, Morcillo C, et al. Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population. J Psychiatr Res 2012; 46:865.</a></li><li><a class="nounderline abstract_t">Quarantini LC, Miranda-Scippa A, Nery-Fernandes F, et al. The impact of comorbid posttraumatic stress disorder on bipolar disorder patients. J Affect Disord 2010; 123:71.</a></li><li><a class="nounderline abstract_t">Simon NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry 2009; 70 Suppl 2:10.</a></li><li><a class="nounderline abstract_t">Bellani M, Hatch JP, Nicoletti MA, et al. Does anxiety increase impulsivity in patients with bipolar disorder or major depressive disorder? J Psychiatr Res 2012; 46:616.</a></li><li><a class="nounderline abstract_t">Hawton K, Sutton L, Haw C, et al. Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors. J Clin Psychiatry 2005; 66:693.</a></li><li><a class="nounderline abstract_t">Neves FS, Malloy-Diniz LF, Corrêa H. Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities? J Clin Psychiatry 2009; 70:13.</a></li><li><a class="nounderline abstract_t">Simon GE, Hunkeler E, Fireman B, et al. Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord 2007; 9:526.</a></li><li><a class="nounderline abstract_t">Nierenberg AA, Miyahara S, Spencer T, et al. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry 2005; 57:1467.</a></li><li><a class="nounderline abstract_t">Klassen LJ, Katzman MA, Chokka P. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord 2010; 124:1.</a></li><li><a class="nounderline abstract_t">McIntyre RS, Kennedy SH, Soczynska JK, et al. Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project. Prim Care Companion J Clin Psychiatry 2010; 12.</a></li><li><a class="nounderline abstract_t">Rydén E, Thase ME, Stråht D, et al. A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD. Acta Psychiatr Scand 2009; 120:239.</a></li><li><a class="nounderline abstract_t">Fornaro M, Daray FM, Hunter F, et al. The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis. J Affect Disord 2021; 280:409.</a></li><li><a class="nounderline abstract_t">Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61:348.</a></li><li><a class="nounderline abstract_t">McElroy SL, Frye MA, Hellemann G, et al. Prevalence and correlates of eating disorders in 875 patients with bipolar disorder. J Affect Disord 2011; 128:191.</a></li><li><a class="nounderline abstract_t">Brietzke E, Moreira CL, Toniolo RA, Lafer B. Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I. J Affect Disord 2011; 130:162.</a></li><li><a class="nounderline abstract_t">McElroy SL, Crow S, Biernacka JM, et al. Clinical phenotype of bipolar disorder with comorbid binge eating disorder. J Affect Disord 2013; 150:981.</a></li><li><a class="nounderline abstract_t">Wildes JE, Marcus MD, Fagiolini A. Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder. Psychiatry Res 2008; 161:51.</a></li><li><a class="nounderline abstract_t">Amerio A, Stubbs B, Odone A, et al. The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis. J Affect Disord 2015; 186:99.</a></li><li><a class="nounderline abstract_t">Lenzenweger MF, Lane MC, Loranger AW, Kessler RC. DSM-IV personality disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 62:553.</a></li><li><a class="nounderline abstract_t">Fan AH, Hassell J. Bipolar disorder and comorbid personality psychopathology: a review of the literature. J Clin Psychiatry 2008; 69:1794.</a></li><li><a class="nounderline abstract_t">Friborg O, Martinsen EW, Martinussen M, et al. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord 2014; 152-154:1.</a></li><li><a class="nounderline abstract_t">Post RM, Leverich GS, McElroy S, et al. Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state. Bipolar Disord 2018; 20:303.</a></li><li><a class="nounderline abstract_t">Swartz HA, Pilkonis PA, Frank E, et al. Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy. Bipolar Disord 2005; 7:192.</a></li><li><a class="nounderline abstract_t">George EL, Miklowitz DJ, Richards JA, et al. The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates. Bipolar Disord 2003; 5:115.</a></li><li><a class="nounderline abstract_t">Greenwood TA, Badner JA, Byerley W, et al. Heritability and linkage analysis of personality in bipolar disorder. J Affect Disord 2013; 151:748.</a></li><li><a class="nounderline abstract_t">Fornaro M, Orsolini L, Marini S, et al. The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis. J Affect Disord 2016; 195:105.</a></li><li><a class="nounderline abstract_t">Zimmerman M, Balling C, Dalrymple K, Chelminski I. Screening for Borderline Personality Disorder in Psychiatric Outpatients With Major Depressive Disorder and Bipolar Disorder. J Clin Psychiatry 2019; 80.</a></li><li><a class="nounderline abstract_t">Cerimele JM, Bauer AM, Fortney JC, Bauer MS. Patients With Co-Occurring Bipolar Disorder and Posttraumatic Stress Disorder: A Rapid Review of the Literature. J Clin Psychiatry 2017; 78:e506.</a></li><li><a class="nounderline abstract_t">Subramaniam M, Abdin E, Vaingankar JA, Chong SA. Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study. J Affect Disord 2013; 146:189.</a></li><li><a class="nounderline abstract_t">Strakowski SM, DelBello MP, Fleck DE, et al. Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry 2007; 64:57.</a></li><li><a class="nounderline abstract_t">Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. JAMA Psychiatry 2016; 73:39.</a></li><li><a class="nounderline abstract_t">Baethge C, Hennen J, Khalsa HM, et al. Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients. Bipolar Disord 2008; 10:738.</a></li><li><a class="nounderline abstract_t">Jaffee WB, Griffin ML, Gallop R, et al. Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. J Clin Psychiatry 2009; 70:171.</a></li><li><a class="nounderline abstract_t">Frye MA, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disord 2006; 8:677.</a></li><li><a class="nounderline abstract_t">Kawa I, Carter JD, Joyce PR, et al. Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation. Bipolar Disord 2005; 7:119.</a></li><li><a class="nounderline abstract_t">Ostacher MJ, Perlis RH, Nierenberg AA, et al. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2010; 167:289.</a></li><li><a class="nounderline abstract_t">Swann AC. The strong relationship between bipolar and substance-use disorder. Ann N Y Acad Sci 2010; 1187:276.</a></li><li><a class="nounderline abstract_t">Gaudiano BA, Uebelacker LA, Miller IW. Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial. Psychiatry Res 2008; 160:63.</a></li><li><a class="nounderline abstract_t">Strakowski SM, DelBello MP, Fleck DE, et al. Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania. Arch Gen Psychiatry 2005; 62:851.</a></li><li><a class="nounderline abstract_t">Hoblyn JC, Balt SL, Woodard SA, Brooks JO 3rd. Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder. Psychiatr Serv 2009; 60:50.</a></li><li><a class="nounderline abstract_t">Goldstein BI, Levitt AJ. A gender-focused perspective on health service utilization in comorbid bipolar I disorder and alcohol use disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2006; 67:925.</a></li><li><a class="nounderline abstract_t">Weiss RD, Ostacher MJ, Otto MW, et al. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry 2005; 66:730.</a></li><li><a class="nounderline abstract_t">Mammen G, Rueda S, Roerecke M, et al. Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies. J Clin Psychiatry 2018; 79.</a></li><li><a class="nounderline abstract_t">Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disord 2008; 10:67.</a></li><li><a class="nounderline abstract_t">van Gorp WG, Altshuler L, Theberge DC, et al. Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study. Arch Gen Psychiatry 1998; 55:41.</a></li><li><a class="nounderline abstract_t">Mazza M, Mandelli L, Di Nicola M, et al. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord 2009; 115:27.</a></li><li><a class="nounderline abstract_t">Kilbourne AM, Perron BE, Mezuk B, et al. Co-occurring conditions and health-related quality of life in patients with bipolar disorder. Psychosom Med 2009; 71:894.</a></li><li><a class="nounderline abstract_t">Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005; 7:187.</a></li><li><a class="nounderline abstract_t">Grunebaum MF, Galfalvy HC, Nichols CM, et al. Aggression and substance abuse in bipolar disorder. Bipolar Disord 2006; 8:496.</a></li><li><a class="nounderline abstract_t">McDermott BE, Quanbeck CD, Frye MA. Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest. Bipolar Disord 2007; 9:536.</a></li><li><a class="nounderline abstract_t">Vornik LA, Brown ES. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry 2006; 67 Suppl 7:24.</a></li><li><a class="nounderline abstract_t">Brown ES. Bipolar disorder and substance abuse. Psychiatr Clin North Am 2005; 28:415.</a></li><li><a class="nounderline abstract_t">Potash JB, Kane HS, Chiu YF, et al. Attempted suicide and alcoholism in bipolar disorder: clinical and familial relationships. Am J Psychiatry 2000; 157:2048.</a></li><li><a class="nounderline abstract_t">Comtois KA, Russo JE, Roy-Byrne P, Ries RK. Clinicians' assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients. Biol Psychiatry 2004; 56:757.</a></li><li><a class="nounderline abstract_t">Sajatovic M, Bauer MS, Kilbourne AM, et al. Self-reported medication treatment adherence among veterans with bipolar disorder. Psychiatr Serv 2006; 57:56.</a></li><li><a class="nounderline abstract_t">Manwani SG, Szilagyi KA, Zablotsky B, et al. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry 2007; 68:1172.</a></li><li><a class="nounderline abstract_t">Forty L, Ulanova A, Jones L, et al. Comorbid medical illness in bipolar disorder. Br J Psychiatry 2014; 205:465.</a></li><li><a class="nounderline abstract_t">Sinha A, Shariq A, Said K, et al. Medical Comorbidities in Bipolar Disorder. Curr Psychiatry Rep 2018; 20:36.</a></li><li><a class="nounderline abstract_t">Magalhães PV, Kapczinski F, Nierenberg AA, et al. Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder. Acta Psychiatr Scand 2012; 125:303.</a></li><li><a class="nounderline abstract_t">Kemp DE, Gao K, Chan PK, et al. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Bipolar Disord 2010; 12:404.</a></li><li><a class="nounderline abstract_t">Thompson WK, Kupfer DJ, Fagiolini A, et al. Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial. J Clin Psychiatry 2006; 67:783.</a></li><li><a class="nounderline abstract_t">Soreca I, Fagiolini A, Frank E, et al. Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder. J Psychiatr Res 2008; 42:956.</a></li><li><a class="nounderline abstract_t">Perron BE, Howard MO, Nienhuis JK, et al. Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2009; 70:1407.</a></li><li><a class="nounderline abstract_t">Leboyer M, Soreca I, Scott J, et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 2012; 141:1.</a></li><li><a class="nounderline abstract_t">Matthews AM, Huckans MS, Blackwell AD, Hauser P. Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders. Bipolar Disord 2008; 10:266.</a></li><li><a class="nounderline abstract_t">Goldstein BI, Liu SM, Zivkovic N, et al. The burden of obesity among adults with bipolar disorder in the United States. Bipolar Disord 2011; 13:387.</a></li><li><a class="nounderline abstract_t">McIntyre RS, Danilewitz M, Liauw SS, et al. Bipolar disorder and metabolic syndrome: an international perspective. J Affect Disord 2010; 126:366.</a></li><li><a class="nounderline abstract_t">Gurpegui M, Martínez-Ortega JM, Gutiérrez-Rojas L, et al. Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample. Prog Neuropsychopharmacol Biol Psychiatry 2012; 37:169.</a></li><li><a class="nounderline abstract_t">Faustino PR, Duarte GS, Chendo I, et al. Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis. JAMA Neurol 2020; 77:192.</a></li><li><a class="nounderline abstract_t">Scott KM, Lim C, Al-Hamzawi A, et al. Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries. JAMA Psychiatry 2016; 73:150.</a></li><li><a class="nounderline abstract_t">Boerman R, Cohen D, Schulte PF, Nugter A. Prevalence of Vitamin D Deficiency in Adult Outpatients With Bipolar Disorder or Schizophrenia. J Clin Psychopharmacol 2016; 36:588.</a></li><li><a class="nounderline abstract_t">Fagiolini A, Frank E, Houck PR, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002; 63:528.</a></li><li><a class="nounderline abstract_t">Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003; 160:112.</a></li><li><a class="nounderline abstract_t">Brietzke E, Moreira CL, Duarte SV, et al. Impact of comorbid migraine on the clinical course of bipolar disorder. Compr Psychiatry 2012; 53:809.</a></li><li><a class="nounderline abstract_t">Carney CP, Jones LE. Medical comorbidity in women and men with bipolar disorders: a population-based controlled study. Psychosom Med 2006; 68:684.</a></li><li><a class="nounderline abstract_t">McIntyre RS, Konarski JZ, Wilkins K, et al. The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache 2006; 46:973.</a></li><li><a class="nounderline abstract_t">Ortiz A, Cervantes P, Zlotnik G, et al. Cross-prevalence of migraine and bipolar disorder. Bipolar Disord 2010; 12:397.</a></li><li><a class="nounderline abstract_t">Fagiolini A, Frank E, Scott JA, et al. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord 2005; 7:424.</a></li><li><a class="nounderline abstract_t">Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med 2008; 38:771.</a></li><li><a class="nounderline abstract_t">Quraishi S, Frangou S. Neuropsychology of bipolar disorder: a review. J Affect Disord 2002; 72:209.</a></li><li><a class="nounderline abstract_t">Solé B, Martínez-Arán A, Torrent C, et al. Are bipolar II patients cognitively impaired? A systematic review. Psychol Med 2011; 41:1791.</a></li><li><a class="nounderline abstract_t">Gitlin MJ. Thinking about cognitive impairment in bipolar disorder: A clinical perspective. Bipolar Disord 2018; 20:578.</a></li><li><a class="nounderline abstract_t">Van Rheenen TE, Lewandowski KE, Bauer IE, et al. Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence. Bipolar Disord 2020; 22:13.</a></li><li><a class="nounderline abstract_t">Roux P, Etain B, Cannavo AS, et al. Prevalence and determinants of cognitive impairment in the euthymic phase of bipolar disorders: results from the FACE-BD cohort. Psychol Med 2019; 49:519.</a></li><li><a class="nounderline abstract_t">Mann-Wrobel MC, Carreno JT, Dickinson D. Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. Bipolar Disord 2011; 13:334.</a></li><li><a class="nounderline abstract_t">Robinson LJ, Thompson JM, Gallagher P, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 2006; 93:105.</a></li><li><a class="nounderline abstract_t">Kurtz MM, Gerraty RT. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology 2009; 23:551.</a></li><li><a class="nounderline abstract_t">Dickinson T, Becerra R, Coombes J. Executive functioning deficits among adults with Bipolar Disorder (types I and II): A systematic review and meta-analysis. J Affect Disord 2017; 218:407.</a></li><li><a class="nounderline abstract_t">Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 2009; 113:1.</a></li><li><a class="nounderline abstract_t">Bourne C, Aydemir Ö, Balanzá-Martínez V, et al. Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand 2013; 128:149.</a></li><li><a class="nounderline abstract_t">Burdick KE, Russo M, Frangou S, et al. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med 2014; 44:3083.</a></li><li><a class="nounderline abstract_t">Miskowiak KW, Seeberg I, Kjaerstad HL, et al. Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force. Bipolar Disord 2019; 21:686.</a></li><li><a class="nounderline abstract_t">Bora E, Pantelis C. Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls. Schizophr Bull 2015; 41:1095.</a></li><li><a class="nounderline abstract_t">Samamé C, Martino DJ, Strejilevich SA. Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study. J Affect Disord 2014; 164:130.</a></li><li><a class="nounderline abstract_t">Sánchez-Morla EM, López-Villarreal A, Jiménez-López E, et al. Impact of number of episodes on neurocognitive trajectory in bipolar disorder patients: a 5-year follow-up study. Psychol Med 2019; 49:1299.</a></li><li><a class="nounderline abstract_t">Torres IJ, Qian H, Basivireddy J, et al. Three-year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder. Acta Psychiatr Scand 2020; 141:98.</a></li><li><a class="nounderline abstract_t">Szmulewicz A, Valerio MP, Martino DJ. Longitudinal analysis of cognitive performances in recent-onset and late-life Bipolar Disorder: A systematic review and meta-analysis. Bipolar Disord 2020; 22:28.</a></li><li><a class="nounderline abstract_t">Bora E, Özerdem A. Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia. Psychol Med 2017; 47:2753.</a></li><li><a class="nounderline abstract_t">Ryan KA, Assari S, Angers K, et al. Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years. Bipolar Disord 2017; 19:689.</a></li><li><a class="nounderline abstract_t">Mora E, Portella MJ, Forcada I, et al. Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study. Psychol Med 2013; 43:1187.</a></li><li><a class="nounderline abstract_t">Depp CA, Mausbach BT, Harmell AL, et al. Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder. Bipolar Disord 2012; 14:217.</a></li><li><a class="nounderline abstract_t">Schretlen DJ, Cascella NG, Meyer SM, et al. Neuropsychological functioning in bipolar disorder and schizophrenia. Biol Psychiatry 2007; 62:179.</a></li><li><a class="nounderline abstract_t">Amann B, Gomar JJ, Ortiz-Gil J, et al. Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls. Psychol Med 2012; 42:2127.</a></li><li><a class="nounderline abstract_t">Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med 2011; 41:225.</a></li><li><a class="nounderline abstract_t">Bora E, Yucel M, Pantelis C. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br J Psychiatry 2009; 195:475.</a></li><li><a class="nounderline abstract_t">Xu G, Lin K, Rao D, et al. Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study. J Affect Disord 2012; 136:328.</a></li><li><a class="nounderline abstract_t">Samamé C, Martino DJ, Strejilevich SA. Social cognition in euthymic bipolar disorder: systematic review and meta-analytic approach. Acta Psychiatr Scand 2012; 125:266.</a></li><li><a class="nounderline abstract_t">Cusi AM, Macqueen GM, McKinnon MC. Patients with bipolar disorder show impaired performance on complex tests of social cognition. Psychiatry Res 2012; 200:258.</a></li><li><a class="nounderline abstract_t">Samamé C. Social cognition throughout the three phases of bipolar disorder: a state-of-the-art overview. Psychiatry Res 2013; 210:1275.</a></li><li><a class="nounderline abstract_t">Bora E, Bartholomeusz C, Pantelis C. Meta-analysis of Theory of Mind (ToM) impairment in bipolar disorder. Psychol Med 2016; 46:253.</a></li><li><a class="nounderline abstract_t">McCraw S, Parker G, Fletcher K, Friend P. Self-reported creativity in bipolar disorder: prevalence, types and associated outcomes in mania versus hypomania. J Affect Disord 2013; 151:831.</a></li><li><a class="nounderline abstract_t">Johnson SL, Murray G, Fredrickson B, et al. Creativity and bipolar disorder: touched by fire or burning with questions? Clin Psychol Rev 2012; 32:1.</a></li><li><a class="nounderline abstract_t">Jamison KR. Great wits and madness: more near allied? Br J Psychiatry 2011; 199:351.</a></li><li><a class="nounderline abstract_t">Srivastava S, Ketter TA. The link between bipolar disorders and creativity: evidence from personality and temperament studies. Curr Psychiatry Rep 2010; 12:522.</a></li><li><a class="nounderline abstract_t">Santosa CM, Strong CM, Nowakowska C, et al. Enhanced creativity in bipolar disorder patients: a controlled study. J Affect Disord 2007; 100:31.</a></li><li><a class="nounderline abstract_t">Tremblay CH, Grosskopf S, Yang K. Brainstorm: occupational choice, bipolar illness and creativity. Econ Hum Biol 2010; 8:233.</a></li><li><a class="nounderline abstract_t">MacCabe JH, Sariaslan A, Almqvist C, et al. Artistic creativity and risk for schizophrenia, bipolar disorder and unipolar depression: a Swedish population-based case-control study and sib-pair analysis. Br J Psychiatry 2018; 212:370.</a></li><li><a class="nounderline abstract_t">Kyaga S, Lichtenstein P, Boman M, et al. Creativity and mental disorder: family study of 300,000 people with severe mental disorder. Br J Psychiatry 2011; 199:373.</a></li><li><a class="nounderline abstract_t">Power RA, Steinberg S, Bjornsdottir G, et al. Polygenic risk scores for schizophrenia and bipolar disorder predict creativity. Nat Neurosci 2015; 18:953.</a></li><li><a class="nounderline abstract_t">Keller MC, Visscher PM. Genetic variation links creativity to psychiatric disorders. Nat Neurosci 2015; 18:928.</a></li><li><a class="nounderline abstract_t">Greenwood TA. Creativity and Bipolar Disorder: A Shared Genetic Vulnerability. Annu Rev Clin Psychol 2020; 16:239.</a></li><li><a class="nounderline abstract_t">McCabe PJ, Christopher PP, Pinals DA, Fisher WH. Predictors of criminal justice involvement in severe mania. J Affect Disord 2013; 149:367.</a></li><li><a class="nounderline abstract_t">Moore KE, Oberleitner LMS, Zonana HV, et al. Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III. J Clin Psychiatry 2019; 80.</a></li><li><a class="nounderline abstract_t">Mundt AP, Chow WS, Arduino M, et al. Psychiatric hospital beds and prison populations in South America since 1990: does the Penrose hypothesis apply? JAMA Psychiatry 2015; 72:112.</a></li><li><a class="nounderline abstract_t">Dean K, Laursen TM, Pedersen CB, et al. Risk of Being Subjected to Crime, Including Violent Crime, After Onset of Mental Illness: A Danish National Registry Study Using Police Data. JAMA Psychiatry 2018; 75:689.</a></li><li><a class="nounderline abstract_t">Verdolini N, Pacchiarotti I, Köhler CA, et al. Violent criminal behavior in the context of bipolar disorder: Systematic review and meta-analysis. J Affect Disord 2018; 239:161.</a></li><li><a class="nounderline abstract_t">Swanson JW, Belden CM. The Link Between Mental Illness and Being Subjected to Crime in Denmark vs the United States: How Much Do Poverty and the Safety Net Matter? JAMA Psychiatry 2018; 75:669.</a></li><li><a class="nounderline abstract_t">Appelbaum PS. Violent Acts and Being the Target of Violence Among People With Mental Illness-The Data and Their Limits. JAMA Psychiatry 2020; 77:345.</a></li><li><a class="nounderline abstract_t">Desmarais SL, Van Dorn RA, Johnson KL, et al. Community violence perpetration and victimization among adults with mental illnesses. Am J Public Health 2014; 104:2342.</a></li><li><a class="nounderline abstract_t">Sariaslan A, Arseneault L, Larsson H, et al. Risk of Subjection to Violence and Perpetration of Violence in Persons With Psychiatric Disorders in Sweden. JAMA Psychiatry 2020; 77:359.</a></li><li><a class="nounderline abstract_t">Chang Z, Larsson H, Lichtenstein P, Fazel S. Psychiatric disorders and violent reoffending: a national cohort study of convicted prisoners in Sweden. Lancet Psychiatry 2015; 2:891.</a></li><li><a class="nounderline abstract_t">Sariaslan A, Lichtenstein P, Larsson H, Fazel S. Triggers for Violent Criminality in Patients With Psychotic Disorders. JAMA Psychiatry 2016; 73:796.</a></li><li><a class="nounderline abstract_t">Crump C, Sundquist K, Winkleby MA, Sundquist J. Comorbidities and mortality in bipolar disorder: a Swedish national cohort study. JAMA Psychiatry 2013; 70:931.</a></li><li><a class="nounderline abstract_t">Staudt Hansen P, Frahm Laursen M, Grøntved S, et al. Increasing mortality gap for patients diagnosed with bipolar disorder-A nationwide study with 20 years of follow-up. Bipolar Disord 2019; 21:270.</a></li><li><a class="nounderline abstract_t">Schaffer A, Isometsä ET, Tondo L, et al. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry 2015; 49:785.</a></li><li><a class="nounderline abstract_t">Dennehy EB, Marangell LB, Allen MH, et al. Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Affect Disord 2011; 133:423.</a></li><li><a class="nounderline abstract_t">Miller JN, Black DW. Bipolar Disorder and Suicide: a Review. Curr Psychiatry Rep 2020; 22:6.</a></li><li><a class="nounderline abstract_t">Schaffer A, Isometsä ET, Azorin JM, et al. A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry 2015; 49:1006.</a></li><li><a class="nounderline abstract_t">Schaffer A, Isometsä ET, Tondo L, et al. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord 2015; 17:1.</a></li><li><a class="nounderline abstract_t">Persons JE, Lodder P, Coryell WH, et al. Symptoms of mania and anxiety do not contribute to suicidal ideation or behavior in the presence of bipolar depression. Psychiatry Res 2022; 307:114296.</a></li><li><a class="nounderline abstract_t">Monson ET, Shabalin AA, Docherty AR, et al. Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach. Transl Psychiatry 2021; 11:379.</a></li><li><a class="nounderline abstract_t">Hawton K, van Heeringen K. Suicide. Lancet 2009; 373:1372.</a></li><li><a class="nounderline abstract_t">Osby U, Brandt L, Correia N, et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58:844.</a></li><li><a class="nounderline abstract_t">Angst J, Angst F, Gerber-Werder R, Gamma A. Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up. Arch Suicide Res 2005; 9:279.</a></li></ol></div><div id="topicVersionRevision">Topic 14642 Version 29.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), Washington, DC 2022.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28919117" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27462036" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27462036" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27816324" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27816324" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Differences in clinical presentation between bipolar I and II disorders in the early stages of bipolar disorder: A naturalistic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21965189" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Sleep disturbance in euthymic bipolar patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12044195" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The long-term natural history of the weekly symptomatic status of bipolar I disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12622659" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20827274" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Transition to mania during treatment of bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24152091" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : First-episode types in bipolar disorder: predictive associations with later illness.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11874212" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Demographic and clinical characteristics of individuals in a bipolar disorder case registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19883943" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Symptoms and signs of the initial prodrome of bipolar disorder: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20836910" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A comprehensive review and model of putative prodromal features of bipolar affective disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18985295" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Diagnosis and treatment in the early illness phase of bipolar disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31479581" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29361850" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Early Intervention in Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26988628" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : The Bidirectional Associations Between Psychotic Experiences and DSM-IV Mental Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20712553" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Diagnosis and monitoring of bipolar disorder in general practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23890763" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : A sib-pair analysis of impulsivity in bipolar disorder type I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19951450" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Item response modeling of DSM-IV mania symptoms in two representative US epidemiological samples.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22578360" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Psychometric evaluation of the DSM-IV criterion B mania symptoms in an Australian national sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22578360" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Psychometric evaluation of the DSM-IV criterion B mania symptoms in an Australian national sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23237861" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Impaired episodic memory for events encoded during mania in patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12832243" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Insurance expenditures on bipolar disorder: clinical and parity implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7623019" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Lack of insight in bipolar disorder. The acute manic episode.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12479664" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Insight into illness in patients with mania, mixed mania, bipolar depression and major depression with psychotic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11136644" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29191030" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Altered Sensory Phenomena Experienced in Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20368510" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Longitudinal course of bipolar I disorder: duration of mood episodes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17368155" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Bipolar disorder--focus on bipolar II disorder and mixed depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16203954" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31004555" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Agitated depression in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30611064" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Hypersomnia and Bipolar Disorder: A systematic review and meta-analysis of proportion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30623823" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Depressive symptoms carry an increased risk for suicidal ideation and behavior in bipolar disorder without any additional contribution of mixed symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14636363" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Foundation Bipolar Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20034673" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Time spent with symptoms in a cohort of bipolar disorder outpatients in Spain: a prospective, 18-month follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17680925" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19922555" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Stability of symptoms across major depressive episodes in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12823083" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23089130" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Mixed states with predominant manic or depressive symptoms: baseline characteristics and 24-month outcomes of the EMBLEM cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23223893" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29105003" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Anxiety, irritability, and agitation as indicators of bipolar mania with depressive symptoms: a post hoc analysis of two clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33418368" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Prevalence of DSM-5 mixed features: A meta-analysis and systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27079133" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1359799" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23122529" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28804990" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Characterizing the experience of auditory verbal hallucinations and accompanying delusions in individuals with a diagnosis of bipolar disorder: A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10929790" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Clinical characteristics of mania, mixed mania, and bipolar depression with psychotic features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30303059" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The characteristics of psychotic features in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28833984" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Psychosis in bipolar disorder: Does it represent a more "severe" illness?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11229983" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17485606" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15939837" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21383262" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27995827" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17156153" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Anxiety disorders and bipolar disorder: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15569893" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22099954" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16816301" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22534180" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19732957" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : The impact of comorbid posttraumatic stress disorder on bipolar disorder patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19371501" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22326294" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Does anxiety increase impulsivity in patients with bipolar disorder or major depressive disorder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15960561" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Suicide and attempted suicide in bipolar disorder: a systematic review of risk factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19026263" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Suicidal behavior in bipolar disorder: what is the influence of psychiatric comorbidities?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17680924" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Risk of suicide attempt and suicide death in patients treated for bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15950022" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19683348" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Adult ADHD and its comorbidities, with a focus on bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20944770" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Attention-deficit/hyperactivity disorder in adults with bipolar disorder or major depressive disorder: results from the international mood disorders collaborative project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19426162" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33227671" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The prevalence, odds and predictors of lifespan comorbid eating disorder among people with a primary diagnosis of bipolar disorders, and vice-versa: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16815322" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20674033" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Prevalence and correlates of eating disorders in 875 patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21071093" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Clinical correlates of eating disorder comorbidity in women with bipolar disorder type I.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23742827" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Clinical phenotype of bipolar disorder with comorbid binge eating disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18782643" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26233320" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : The prevalence and predictors of comorbid bipolar disorder and obsessive-compulsive disorder: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17217923" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : DSM-IV personality disorders in the National Comorbidity Survey Replication.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19026249" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Bipolar disorder and comorbid personality psychopathology: a review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24120406" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29369448" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Prevalence of axis II comorbidities in bipolar disorder: relationship to mood state.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15762861" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Acute treatment outcomes in patients with bipolar I disorder and co-morbid borderline personality disorder receiving medication and psychotherapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12680901" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The comorbidity of bipolar disorder and axis II personality disorders: prevalence and clinical correlates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23972719" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Heritability and linkage analysis of personality in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26881339" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : The prevalence and predictors of bipolar and borderline personality disorders comorbidity: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30677270" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Screening for Borderline Personality Disorder in Psychiatric Outpatients With Major Depressive Disorder and Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28570791" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Patients With Co-Occurring Bipolar Disorder and Posttraumatic Stress Disorder: A Rapid Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23017543" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Prevalence, correlates, comorbidity and severity of bipolar disorder: results from the Singapore Mental Health Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17199055" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26580136" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Epidemiology of DSM-5 drug use disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18837869" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Sequencing of substance use and affective morbidity in 166 first-episode bipolar I disorder patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19192456" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17156154" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15762852" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Gender differences in bipolar disorder: age of onset, course, comorbidity, and symptom presentation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20008948" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20201858" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : The strong relationship between bipolar and substance-use disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18514326" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Impact of remitted substance use disorders on the future course of bipolar I disorder: findings from a clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16061762" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Effects of co-occurring alcohol abuse on the course of bipolar disorder following a first hospitalization for mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19114570" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16848652" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : A gender-focused perspective on health service utilization in comorbid bipolar I disorder and alcohol use disorders: results from the national epidemiologic survey on alcohol and related conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15960566" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Does recovery from substance use disorder matter in patients with bipolar disorder?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29877641" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Association of Cannabis With Long-Term Clinical Symptoms in Anxiety and Mood Disorders: A Systematic Review of Prospective Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18199243" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9435759" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Cognitive impairment in euthymic bipolar patients with and without prior alcohol dependence. A preliminary study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18845344" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19661187" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Co-occurring conditions and health-related quality of life in patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15762860" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17042888" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Aggression and substance abuse in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17680926" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Comorbid substance use disorder in women with bipolar disorder associated with criminal arrest.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16961421" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Management of comorbid bipolar disorder and substance abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15826740" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Bipolar disorder and substance abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11097977" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Attempted suicide and alcoholism in bipolar disorder: clinical and familial relationships.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15556120" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Clinicians' assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16399963" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Self-reported medication treatment adherence among veterans with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17854240" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25359927" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Comorbid medical illness in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29732528" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Medical Comorbidities in Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22098628" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Illness burden and medical comorbidity in the Systematic Treatment Enhancement Program for Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20636638" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16841628" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: analysis of acute-phase data from a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18076906" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Relationship of general medical burden, duration of illness and age in patients with bipolar I disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19906344" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Prevalence and burden of general medical conditions among adults with bipolar I disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22497876" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Can bipolar disorder be viewed as a multi-system inflammatory disease?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18271905" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Hepatitis C testing and infection rates in bipolar patients with and without comorbid substance use disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21843278" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : The burden of obesity among adults with bipolar disorder in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20541810" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Bipolar disorder and metabolic syndrome: an international perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22326681" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Overweight and obesity in patients with bipolar disorder or schizophrenia compared with a non-psychiatric sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31609378" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26719969" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Association of Mental Disorders With Subsequent Chronic Physical Conditions: World Mental Health Surveys From 17 Countries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27662458" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Prevalence of Vitamin D Deficiency in Adult Outpatients With Bipolar Disorder or Schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12088166" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Prevalence of obesity and weight change during treatment in patients with bipolar I disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12505809" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Obesity as a correlate of outcome in patients with bipolar I disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22104557" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Impact of comorbid migraine on the clinical course of bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17012521" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Medical comorbidity in women and men with bipolar disorders: a population-based controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16732843" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20636637" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : Cross-prevalence of migraine and bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16176435" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17922938" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12450638" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Neuropsychology of bipolar disorder: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21275085" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Are bipolar II patients cognitively impaired? A systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30259608" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : Thinking about cognitive impairment in bipolar disorder: A clinical perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31408230" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29734950" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : Prevalence and determinants of cognitive impairment in the euthymic phase of bipolar disorders: results from the FACE-BD cohort.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21843273" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16677713" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19702409" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28501741" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Executive functioning deficits among adults with Bipolar Disorder (types I and II): A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18684514" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23617548" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25065409" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31491048" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : Affective cognition in bipolar disorder: A systematic review by the ISBD targeting cognition task force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25616505" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24856566" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Longitudinal course of cognitive deficits in bipolar disorder: a meta-analytic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30043716" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Impact of number of episodes on neurocognitive trajectory in bipolar disorder patients: a 5-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31840225" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : Three-year longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31541587" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Longitudinal analysis of cognitive performances in recent-onset and late-life Bipolar Disorder: A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28585513" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Meta-analysis of longitudinal studies of cognition in bipolar disorder: comparison with healthy controls and schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28906586" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Equivalent linear change in cognition between individuals with bipolar disorder and healthy controls over 5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22935452" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Persistence of cognitive impairment and its negative impact on psychosocial functioning in lithium-treated, euthymic bipolar patients: a 6-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22548895" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Meta-analysis of the association between cognitive abilities and everyday functioning in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17161829" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Neuropsychological functioning in bipolar disorder and schizophrenia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22357405" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Executive dysfunction and memory impairment in schizoaffective disorder: a comparison with bipolar disorder, schizophrenia and healthy controls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20836900" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19949193" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22169253" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Neuropsychological performance in bipolar I, bipolar II and unipolar depression patients: a longitudinal, naturalistic study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22211280" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Social cognition in euthymic bipolar disorder: systematic review and meta-analytic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22854176" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Patients with bipolar disorder show impaired performance on complex tests of social cognition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24075306" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Social cognition throughout the three phases of bipolar disorder: a state-of-the-art overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26456502" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Meta-analysis of Theory of Mind (ToM) impairment in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24084622" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Self-reported creativity in bipolar disorder: prevalence, types and associated outcomes in mania versus hypomania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22088366" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Creativity and bipolar disorder: touched by fire or burning with questions?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22045939" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Great wits and madness: more near allied?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20936438" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : The link between bipolar disorders and creativity: evidence from personality and temperament studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17126406" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : Enhanced creativity in bipolar disorder patients: a controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20138016" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Brainstorm: occupational choice, bipolar illness and creativity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29697041" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : Artistic creativity and risk for schizophrenia, bipolar disorder and unipolar depression: a Swedish population-based case-control study and sib-pair analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21653945" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Creativity and mental disorder: family study of 300,000 people with severe mental disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26053403" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Polygenic risk scores for schizophrenia and bipolar disorder predict creativity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26108717" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : Genetic variation links creativity to psychiatric disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32040337" id="rid180" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>181 : Creativity and Bipolar Disorder: A Shared Genetic Vulnerability.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23477847" id="rid181" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>182 : Predictors of criminal justice involvement in severe mania.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30758921" id="rid182" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>183 : Psychiatric Disorders and Crime in the US Population: Results From the National Epidemiologic Survey on Alcohol and Related Conditions Wave III.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25471050" id="rid183" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>184 : Psychiatric hospital beds and prison populations in South America since 1990: does the Penrose hypothesis apply?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29799904" id="rid184" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>185 : Risk of Being Subjected to Crime, Including Violent Crime, After Onset of Mental Illness: A Danish National Registry Study Using Police Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30014956" id="rid185" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>186 : Violent criminal behavior in the context of bipolar disorder: Systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29799908" id="rid186" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>187 : The Link Between Mental Illness and Being Subjected to Crime in Denmark vs the United States: How Much Do Poverty and the Safety Net Matter?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31940025" id="rid187" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>188 : Violent Acts and Being the Target of Violence Among People With Mental Illness-The Data and Their Limits.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24524530" id="rid188" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>189 : Community violence perpetration and victimization among adults with mental illnesses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31940015" id="rid189" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>190 : Risk of Subjection to Violence and Perpetration of Violence in Persons With Psychiatric Disorders in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26342957" id="rid190" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>191 : Psychiatric disorders and violent reoffending: a national cohort study of convicted prisoners in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27410165" id="rid191" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>192 : Triggers for Violent Criminality in Patients With Psychotic Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23863861" id="rid192" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>193 : Comorbidities and mortality in bipolar disorder: a Swedish national cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30051555" id="rid193" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>194 : Increasing mortality gap for patients diagnosed with bipolar disorder-A nationwide study with 20 years of follow-up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26185269" id="rid194" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>195 : Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21601286" id="rid195" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>196 : Suicide and suicide attempts in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31955273" id="rid196" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>197 : Bipolar Disorder and Suicide: a Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26175498" id="rid197" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>198 : A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: Part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25329791" id="rid198" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>199 : International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34852976" id="rid199" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>200 : Symptoms of mania and anxiety do not contribute to suicidal ideation or behavior in the presence of bipolar depression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34234108" id="rid200" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>201 : Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19376453" id="rid201" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>202 : Suicide.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11545667" id="rid202" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>203 : Excess mortality in bipolar and unipolar disorder in Sweden.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16020171" id="rid203" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>204 : Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years' follow-up.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
